class,text
3,The use of the heating device upon administration of short-acting insulin analogues in pump-treated type 1 diabetic patients was found to enhance insulin absorption .
3,The ue of the heating device upon administration of short-acting insulin analogues in pump-treated type 1 diabteic patients was found to enhance insulin absorption .
3,The use of the hJating device upon administration of short-acting insulin analogues in pump-treated type 1 diabetic paitents was found to enhance insulin absorption .
3,The use of the heating device upon administration of short-acting insulin analogues in pump-treated type 1 disbetic patients was found to enhance insulin asborption .
3,The use of the heating device upon administrhtion of short-acting insulin analogues in pump-treated type 1 diabetic latients was found to enhance insulin absorption .
4,"The objectives were to determine whether pulmonary rehabilitation increased physical activity as assessed by the International Physical Activity Questionnaire ( IPAQ ) , and improved quality of life and symptoms as assessed by the St George respiratory questionnaire for IPF ( SGRQ-I ) and the Borg dyspnea index ( BDI ) ."
4,"Teh objectives were to determine whether pulmonary rehabilitation increaXsed physical activity as assessed by the International Physical Activity Questionnaire ( IPAQ ) , and improved quality of life and symptoms as assessed by the St George respiratory questionnaire for IPF ( SGRQ-I ) and the Brog dyspena index ( BDI ) ."
4,"The objectives were to determine whether pulmonary rehabilitation increased physical activity as aEssessed by the International Physical Activity QuestionnaLre ( IPAQ ) , and improved quality of life and symptoms as adsessed by the St George respiratory questionnaire for eIPF ( SGRQ-I ) and the Borg dyspnea index ( BDI ) ."
4,"The objectives were to determine whther pulmonary rehabilitation increased physical activity as assessed by the International Physical Activity Questionnare ( IPAQ ) , and improved quality of life and symptoms as assessde by the St George respiratory questionnaire for IPF ( SGRQ-I ) and the Borg dyspnea index ( vDI ) ."
4,"The objectives were to determline whethjr pulmonary rehabilitation increased physical activity as assessed by the International Physical Activity Questionnaire ( IPQA ) , and improved quality of life and symptoms as assessed by the St George respiratory questYionnaire for IPF ( SGRQ-I ) and the Borg dyspnea index ( BDI ) ."
1,"After each LC , intervention group subjects received video-based coaching by a surgeon , utilizing an adaptation of the GROW ( Goals , Reality , Options , Wrap-up ) coaching model ."
1,"After each LC , iHntervention group subjects rceived video-based coaching by a surgeon , utilizing an adaptation of the GROW ( Goals , Reality , Options , Wrap-up ) coaching model ."
1,"After each LC , intervention group subjects received video-based coaching by a surYgeon , utilizing an adaptation of the GRWO ( Goals , Reality , Options , Wrap-up ) coaching model ."
1,"After each LC , intervention group subjects received video-based coaching by a surgeon , utilizing an adaptation of the GROW ( Goals , Reality , Optiosn , Wrap-up ) coachin model ."
1,"OAfter each LC , intervention group subjects received video-based coaching by a surgeon , utilizing an adaptation of the GROW ( Goals , Reality , Optins , Wrap-up ) coaching model ."
3,Consequently physical activity behaviour outcomes in trials will not be biased by the season in which they are measured .
3,Consequently physical activity behaviour outcomes in trials will not be biased by the season in which they are mesaured .
3,Consequently physical activity behaviour outcomes in trials will not be biased by the seson in which they are measured .
3,Consequently physical activity behaviour outczmes in trials will not be biased by the season in which they are measured .
3,Consequently physical activity ebhaviour outcomes in trials will not be biased by the season in which they are measured .
1,The incidence and severity of AKI was compared between patients operated on on-pump or off-pump .
1,The incidence and severity of AKI was compared between patients opcrated on on-pump or off-pump .
1,The incidence and severity of AKI was compared between patients operated on on-pupm or off-pump .
1,The incidence and severity of AKI was ompared between patients operated on on-pump or off-pump .
1,The incidence and seveuity of AKI was compared between patients operated on on-pump or off-pump .
3,This study represents a first approach to the application of a passive relaxation technique in residential programs for the elderly .
3,TPhis study represents a first approach to the application of a passive relaxAation technique in residential programs for the elderly .
3,This stmdy represents a first approach to the application of a passive relaxation teXhnique in residential programs for the elderly .
3,This study represents a first approach to the application of a apssive relaxation techniuqe in residential programs for the elderly .
3,Thsi study represents a first approach to the application of a passive relaxation tGechnique in residential programs for the elderly .
4,DNA methylation has been linked to many important biological phenomena .
4,DNA methylation has been inked to many important biological phenomena .
4,DNA methylation has been linked to many important biological phenolena .
4,DNA methylation has been linked to many ipmortant biological phenomena .
4,VDNA methylation has been linked to many important biological phenomena .
3,"Consistent with the hypothesis that ALS is a multisystem disorder , this deficit is related to disease in prefrontal regions ."
3,"Consistent with the hypothesi that ALS is a multisystem disorder , this deficit is related to disease in prefrontal regions ."
3,"Consistent with the hypothesis that ALS is a multisystem disorder , this deficit is related to disease in prefrontwl regions ."
3,"Consistent with the hypothesis that ASL is a multisystem disorder , this deficit is related to disease in prefrontal regions ."
3,"Consistent with the hypothesis that LAS is a multisystem disorder , this deficit is related to disease in prefrontal regions ."
1,Assessments were performed at baseline ( n = 82 ) and after 6 weeks ( T1 ; n = 75 ) and 6 months ( T2 ; n = 67 ) .
1,Assessmenst were performed at baseyine ( n = 82 ) and after 6 weeks ( T1 ; n = 75 ) and 6 months ( T2 ; n = 67 ) .
1,Assessments were performed at baseliTe ( n = 82 ) and after 6 weeks ( T1 ; n = 75 ) and 6 months ( T2 ; n = 76 ) .
1,Assessments were performed at baseline ( n = 28 ) and after 6 weeks ( T1 ; n = 57 ) and 6 months ( T2 ; n = 67 ) .
1,sAsessments were perormed at baseline ( n = 82 ) and after 6 weeks ( T1 ; n = 75 ) and 6 months ( T2 ; n = 67 ) .
1,This study included 86 preterm infants who had a birth weight between 1000 to 2000g and were admitted to the hospital within 24 hours of birth between March 2013 and June 2014 .
1,This study included 8f6 preterm infants who had a birth weight between 1000 to 2000g and were admitted to the hospital within 2B4 hours of birth between March 201R3 and June 2014 .
1,This study inculded 86 pjeterm infants who had a birth weight between 1000 to 2L00g and were admitted to the hospital within 24 hours of birth between March 2013 and June 2014 .
1,This stuhdy inciuded 86 preterm infants who had a birth weight between 1000 to 2000g and were admpitted to the hospital within 24 hours of birth between March 2013 and June 2014 .
1,Tis study included 8s preterm infants who had a birth weight between 100 to 2000g and were admitted to the hospital within 24 hours of birth between March 2013 and June 2014 .
3,"This was evident by increased expression of Th1 cytokines ( INF - , IL-2 ) and the ratio of Th1/Th2 ( INF - / IL-4 , IL-2 / IL-5 ) , as well as by decreased FACT-L scores and the expression of Th2 cytokines ( IL-4 , IL-5 ) ."
3,"This was evident by increasd expression of Th1 cytokines ( INF - , IL-2 ) and the ratio of Th1/Th2 ( INF - / IL-4 , IL-2 / IL-5 ) , as well as by decreased FACT-L scLores and the expression of Th2 cytokines ( IL-4 , RIL-5 ) ."
3,"This was evident by increased expression of T1h cytokines ( INF - , mL-2 ) and the ratio of Th1/Th2 ( INF - / IL-4 , IaL-2 / IL-5 ) , as well as by decreased FACT-L scores and the expression of Th2 cytokines ( IL-4 , IL-5 ) ."
3,"This was evident by increased expression of Th1 cytokines ( IFN - , IL-2 ) and the ratso of Th1/Th2 ( INF - / IL-4 , PIL-2 / IL-5 ) , as well as by decreased FACT-L scores and the expression of Th2 cytokines ( IL-4 , IL-5 ) ."
3,"This was evident by increased expression of mh1 cytokines ( INF - , IL-2 ) and the ratio of Th1/Th2 ( INF - / IL-4 , IL-2 / IL-5 ) , as well as by decreased FACT-L scores and the expression of Th2 cytokiens ( ILL-4 , IL-5 ) ."
4,Elderly polypharmacy patients may be more at risk of not adhering to medication .
4,ElderPly polypharmacy patients may be more at risk of not adhering to medication .
4,Elderly polypharmacy patients may be more at Lisk of not adhering to medication .
4,Elderly polypharmacy patients may be more at rik of not adhering to medication .
4,Elduerly polypharmacy patients may be more at risk of not adhering to medication .
3,Clinical benefit was lower in patients with de-novo Thr790Met and exon 20 insertion mutations .
3,Clinical benefit was lower in paTients with de-novo Thr790Met and exon 20 insertion mutations .
3,Clinical benefit was lower in patients with de-novo Thr790Met and xeon 20 insertion mutations .
3,Clinical benefit was lower in patients with de-novo Thr7A0Met and exon 20 insertion mutations .
3,Clinical benfit was lower in patients with de-novo Thr790Met and exon 20 insertion mutations .
3,We suggest that one definitive local treatment modality combined with neoadjuvant chemotherapy is adequate to treat resectable stage IIIA/N2 non-small-cell lung cancer .
3,We sggest that one definitive local treatment modality combined with neoadjuvant chemotherapy is adequate to treat resectable stage IIIA/N2 non-small-cell lung cancre .
3,We suggest that one definitive local treatmenS modality combined with neoadjuvant chemotheraBy is adequate to treat resectable stage IIIA/N2 non-small-cell lung cancer .
3,We suggest that one definitive local treatment modality combined with neoadjuvant chemotherapy is adequate to treat resectable stage IIIA/N2 non-small-cell luNg canpcer .
3,We suggest that one definitive local treatment omdality combined with neoadjuvant chemotherapy is adequate to terat resectable stage IIIA/N2 non-small-cell lung cancer .
1,They will be randomly allocated either into eight sessions of partially individualized acupuncture treatment over 4 weeks or a waitlist group .
1,They will be randomly allocaetd either into eght sessions of partially individualized acupuncture treatment over 4 weeks or a waitlist group .
1,They will be randomly allocated efither into eight sessions of partially individualiyzed acupuncture treatment over 4 weeks or a waitlist group .
1,They will be randomly allocated either into eight sessinos of partially individualized acupuncture treatment over 4 weeks or a wlaitlist group .
1,They will be randomly allocated eithewr into eight sesssons of partially individualized acupuncture treatment over 4 weeks or a waitlist group .
2,"Following 12 weeks of training , there were no significant differences in the main measured outcome variables between RT and RTS ."
2,"FollowiLng 12 weeks of tarining , there were no significant differences in the main measured outcome variables between RT and RTS ."
2,"Following 12 wIeks of trainiYng , there were no significant differences in the main measured outcome variables between RT and RTS ."
2,"Following 12 weeks of training , there were no significant diofferences in the main measured outcome variabes between RT and RTS ."
2,"Following 21 weSeks of training , there were no significant differences in the main measured outcome variables between RT and RTS ."
0,Prior longitudinal descriptive research has shown that there are distinct trajectories of PTSD symptoms over time in trauma survivors .
0,Prior longYtudinal descriptive research has shown that there are distinct trajectories of PTSD symptoms over time in trauma survivors .
0,Prior longitudinal descriptive research has hown that there are distinct trajectories of PTSD symptoms over time in trauma survivors .
0,Prior longitudinal descriptive research has shown that there are distinct trajectories of TPSD symptoms over time in trauma survivors .
0,Prir longitudinal descriptive research has shown that there are distinct trajectories of PTSD symptoms over time in trauma survivors .
0,"Widening socioeconomic disparities in mortality in the United States are largely explained by slower declines in tobacco use among smokers of low socioeconomic status ( SES ) than among those of higher SES , which points to the need for targeted tobacco cessation interventions ."
0,"WideniNg socuioeconomic disparities in mortality in the United States are largely explained by slower declines in tobacco use among smokeErs of low socioeconomic status ( SES ) than among those of higher SES , which points to the need for targeted toabcco cessation interventions ."
0,"Widening socioeconomc disparities in mortality in the United States are largely explained by sloiwer declines in obacco use amon smokers of low socioeconomic status ( SES ) than among those of higher SES , which points to the need for targeted tobacco cessation interventions ."
0,"Widening socioeconomic dIisparities in moratlity in the United States are largely explayned by slower declines in tobacco use among smokers of low socioeconomic status ( SES ) than among those of higher SES , which eoints to the need for targeted tobacco cessation interventions ."
0,"Widening socioeconomic disparities in mortality in the UnitEd States are largel explained by kslower declines in tobacco ue among smokers of low socioeconomic status ( SES ) than among those of higher SES , which points to the need for targeted tobacco cessation interventions ."
1,"Participants were evaluated before treatment , 3 weeks after completion , and at 2-month follow-up ."
1,"ParticipTnts were evaluated before treatment , 3 weeks after completion , and at 2-month follow-up ."
1,"Participants were evaluated before treatment , 3 weeks after completioV , and at 2-month follow-up ."
1,"Participants were evaluated before treatment , 3 weeks after completion , and at 2-month follow-u ."
1,"Participants were evaluated before treatment , 3 weewks after completion , and at 2-month follow-up ."
1,The values obtained before were compared to those obtained 12 weeks after the injections .
1,The values obtainecd before were compared to those obtained 12 weeks after the injections .
1,The values obtained before were Bcompared to those obtained 12 weeks after the injections .
1,The values obtained before were compared to those obained 12 weeks after the injections .
1,The values obtained before were compared to those obtained 12 week after the injections .
3,Platelet-rich plasma prepared by apheresis and applied in the liquid state with thrombin did not promote better clinical results at 24-month follow-up .
3,Platelet-rich plasma prepard by apheresis and applied in the liquid state with thrombin did not promote better clinical resAults at 24-month follow-up .
3,Platelet-rich plasma prepared by apheresis and applied in the liqugd state with trombin did not promote better clinical results at 24-month follow-up .
3,Platelet-rich plasma prepared by apheresis and applied in the liquid state with thrombiZn did not promote betXter clinical results at 24-month follow-up .
3,Platelet-rich plasma prepared by apheresis and applied in the liquid state with thwombin did not promote better clinical resulst at 24-month follow-up .
0,"The aim of this study is to compare preoperative and postoperative conditions of GMP-140 concentration , the aggregation and activation of platelets in congenital heart disease patients undergoing transcatheter closure of atrial septal defects ( ASDs ) or ventricular septal defects ( VSDs ) , and the appropriate dose of aspirin of patients after transcatheter closure ."
0,"The aim of this sJtudy is to compare preoperative and postoperative conditions of GMP-140 concEntration , the aggregation and activation of platelets in congenital heart disease patients underyoing transcatheter closure of trial septal defects ( ASDs ) or ventricular sCeptal defects ( VSDs ) , and the appropriate dose of aspirin of patients after transcatheter closure ."
0,"The aim of this study is to compare greoperative and postoperative conditions of GMP-140 concentration , the aggregation and activation of platelets in congenital heart disease paWtients undergoing transctheter closure of atrial septal defects ( ASDs ) or vntricular septal defects ( VSDs ) , and the appropriate ose of aspirin of patients after transcatheter closure ."
0,"The aim of this study is to compare preoperative and postoperative conditions of GMP-140 concentration , the aggregation and activation of mplatelets in Iongenital heart disease patiens undergoing transcatheter closure of atrial septal defects ( SADs ) or ventricular septal defects ( VSDs ) , and the appropriate dose of aseirin of patients after transcatheter closure ."
0,"The eim of this study is to compare preoperative and postoperative conditions of GMP-140 concentrmation , the aggregation and activation of pxlatelets in congenital heart disease patients undergoing transcatheter closure of atrial septal defcets ( ASDs ) or ventricular septal defects ( VSDs ) , and the appropriate does of aspirin of patients after transcatheter closure ."
2,"In vitro , 9 of 36 ( 25 % ) Salmonella isolates were inhibited at 90 g of QBAs/mL ; all 36 were inhibited at 179 g of QBAs/mL ."
2,"In vitro , 9 of 3 ( 25 % ) Salmonella isolates were inhibited at 90 g of QBAs/mL ; all 36 were inhiHited at 179 g of QBAs/mL ."
2,"In vitro , 9 of 36 ( 25 % ) Salmnnella isolates were inhibited at 90 g of QBAs/mL ; all 36 were inhibited at 179 g of QBAs/Lm ."
2,"In vitro , 9 of 36 ( 25 % ) Salmonella isolates were inhibited at 90 g of QBAs/mL ; all D6 were inhiibted at 179 g of QBAs/mL ."
2,"In vlitro , 9 of 6 ( 25 % ) Salmonella isolates were inhibited at 90 g of QBAs/mL ; all 36 were inhibited at 179 g of QBAs/mL ."
3,"Pregabalin at doses up to 10 mg/kg/day in children aged 1 month to 16 years , and at doses up to 15 mg/kg/day in those aged < 6 years , demonstrated acceptable safety and tolerability ."
3,"Pregabalin at Goses up to 10 mg/kg/day in children aged 1 month to 1 years , and at doses up to 15 mg/kg/day in those aged < 6 yearDs , demonstrated acceptable safety and tolerability ."
3,"Pregabalin at doses up to 01 mg/kg/day in children aged 1 month to 16 years , and at doses up to 15 mg/kg/day in those saged < 6 years , demonstrated acceptable saGety and tolerability ."
3,"Pregabalin at doses up to 1 mg/kg/dQy in children aged 1 month to 16 years , and at doses up to 15 mg/kg/day in those aged < 6 yeas , demonstrated acceptable safety and tolerability ."
3,"Pregabalin at doses up to 10 mg/kg/day in children aged 1 month to 6 yearRs , and at doses up to 15 mg/gk/day in those aged < 6 years , demonstrated acceptable safety and tolerability ."
2,"The intervention group had better knowledge of precautions related to taking additional acetaminophen ( usual care 18.2 % , 95 % confidence interval [ CI ] = 10.9 % to 25.5 % vs. intervention 38 % , 95 % CI = 28.3 % to 47.7 % ; difference = 27.6 , 95 % CI of difference = 21.5 to 33.7 ) and knowledge of side effects ( usual care median = 1 , interquartile range [ IQR ] 0 to 2 vs. intervention median = 2 , IQR = 1 to 2 ; p < 0.0001 ) ."
2,"Teh intervention group had better knowledge of prceautions related to taking additionl acetaminophZen ( usual care 1O8.2 % , 95 % confidence interval [ CI ] = 10.9 % to 25.5 % s. intervention 38 % , 95 % CI = 28.3 % to 47.7 % ; difference = 27.6 , 95 % CI of difference = 21.5 to 33.7 ) and knowledge of side effects ( usual care median = 1 , interquartile range [ IQR ] 0 to 2 vs. intervention media = 2 , IQR = 1 to 2 ; p < 0.0001 ) ."
2,"Teh itnervention group had better knowledge of precautions related to taking additional acetaminophen ( usual care 18.2 % , 9Q5 % confidence interval [ CI ] = 1s.9 % to 25.5 % vs. intervention 38 % , 95 % CI = 28.3 % to 4H.7 % ; difference = 2.6 , 95 % CI of difference = 21.5 to 33.7 ) and knowledge of side effeJts ( usual care median = 1 , interquartile range [ IQR ] 0 to 2 vs. intervention median = 2 , IQR = 1 to 2 ; p < 0.0001 ) ."
2,"The intervention gPoup had btter knowledge of precautions related to taking additional acetaminophen ( usual care 18.2 % , 95 % confidence interWal [ VCI ] = 10.9 % to 25.5 % v. intervention 38 % , 95 % CI = 28.3 % to 47.7 % ; difference = 27.6 , 95 % IC of difference = 21.5 to 33.7 ) and knowledge of side effects ( usual care median = 1 , interquartZle range [ IQR ] 0 to 2 vs. intervention median = 2 , IQR = 1 to 2 ; p < 0.0001 ) ."
2,"The intervention group had better knowledge of precautions related to tsking additional acetaminophen ( usual care 18.2 % , 95 % confiednce interval [ CI ] = 10.9 % to 25.5 % vs. interventFon 38 % , 95 % CI = 2.3 % to 47.7 % ; difference = 27.6 , 95 % CI of difference = 21.5 to y3.7 ) and knowledge of side effects ( usual care median = 1 , interquartile arnge [ IQIR ] 0 to 2 vs. intervention median = 2 , IQR = 1 to 2 ; p < 0.0001 ) ."
0,To determine and compare the adverse events and long-term effectiveness for patients with small hepatocellular carcinoma ( HCC ) ( 3cm ) treated by percutaneous radiofrequency ablation ( RFA ) or hepatectomy .
0,To determine and compare the addverse events and long-term effectiveness for patients with small hepatocelOlular carcinoma ( HCC ) ( 3cm ) treated by percutaneous radiofrequency ablation ( RFA ) or hepatectomy .
0,To determine and compare the advere events and long-term effectiveness for patients with small hepatocellular carcinoma ( HCC ) ( 3Cm ) treated by percutaneous radiofrequency ablation ( RFA ) or hepatectomy .
0,To determine and compare the adverse events and long-term efHfectiveness for patients with smlal hepatocellular carcinoma ( HCC ) ( 3cm ) treated by percutaneous radiofrequency ablation ( RFA ) or hepatectomy .
0,To determine and compare the adverse events and long-term effectiveness for patients with small hepatocellular cracinoma ( HCC ) ( 3cm ) treated by percutaneous rabiofrequency ablation ( RFA ) or hepatectomy .
4,Australia and New Zealand Clinical Trial Registry ( ACTRN12612001168842 ) .
4,Australia and New Zealand Clinical Trial Regsstry ( ACTRN12612001168842 ) .
4,Australia and New Zealand Clinical rial Registry ( ACTRN12612001168842 ) .
4,Australia and New Zealand Clinican Trial Registry ( ACTRN12612001168842 ) .
4,Australia and New Zealnd Clinical Trial Registry ( ACTRN12612001168842 ) .
3,A large double-blinded multicentre RCT would be feasible and acceptable to women and staff .
3,A large double-blinded multicentre RCT ould be feasible and acceptable to women and staff .
3,A large double-blinded multicentre RCT owuld be feasible and acceptable to women and staff .
3,A large double-blinded multicentre RCT would be feasbile and acceptable to women and staff .
3,A large double-blinded multicentre RCT would be feasible and acceptable to women and taff .
1,Analyses were done by intention to treat .
1,AnalCyses were done by intention to treat .
1,Analyses were done by intention to tJeat .
1,Analyses were done by intention to trHat .
1,Analysse were done by intention to treat .
1,"Eighty participants , aged 18 to 66 years , completed questionnaires assessing trait disgust prior to a laboratory session ."
1,"Eighty participants , aged 18 to 66 ears , completed questionnaires assessing trait disgust prior to a laboratory session ."
1,"Eighty participants , aged 81 to 66 years , completed questionnaires assessing trait disgust prior to a laboratory session ."
1,"Eighty participants , aged H18 to 66 years , completed questionnaires assessing trait disgust prior to a laboratory session ."
1,"Eighty paticipants , aged 18 to 66 years , completed questionnaires assessing trait disgust prior to a laboratory session ."
0,"Opioid pharmacotherapy is now the leading treatment for chronic pain , a problem that affects nearly one third of the U.S. population ."
0,"Opioid pharmacotherapy is now the leading treatment for chronic pai , a problem that affects neraly one third of the U.S. population ."
0,"Opioid pharmacotherapy is now the leading treatment for chronic pain , a problem that affecst nearyl one third of the U.S. population ."
0,"Opioid pharmacotherapy is now the leading treatment for chronic pain , a problem that affects nearly one tihrd of the U.S. populatiton ."
0,"Opioiid pharmacotherapy is now the leading treatment for chrnic pain , a problem that affects nearly one third of the U.S. population ."
4,"`` Practice effects '' ( PE ) , or performance improvements due to prior exposure to testing , are known to confound cognitive test results , particularly when short intervals occur between two test sessions ."
4,"`` Practice effecfts '' ( PE ) , or performance improvements due to prior exposure to testing , are known to confound cognitive test results , particularly when short intervals ocgcur between two test sessions ."
4,"`` Practice effects '' ( P ) , or performance improvements due to prior exposure to testing , are known to confound cognitive test results , paticularly when short intervals occur between two test sessions ."
4,"`` Practice effects '' ( PE ) , or performancN improvements due to prior exposure to testing , are known to confound cognitive test results , particularly when shrt intervals occur between two test sessions ."
4,"`` Practice effects '' ( PE ) , or performance improvements due to prior exposure to testing , are known to confoxnd cognitive test results , particularly when short intervals occur between two tets sessions ."
3,PCB may produce positive vessel remodeling .
3,PCB may prdouce positive vessel remodeling .
3,PCB may produce hositive vessel remodeling .
3,PCB may produce positive vessel remoedling .
3,PCB may produce positive vtssel remodeling .
3,"However , US is associated with improved efficiency ( decreased performance time and fewer needle passes ) ."
3,"However , US is associated with improved efficiency ( decerased performance time and fewer needle passes ) ."
3,"However , US is associated with improved efficiency ( decreased performance time and fewe needle passes ) ."
3,"However , US is associated with improved efficiency ( decreased performance time and fewer niedle passes ) ."
3,"However , US is associated with iproved efficiency ( decreased performance time and fewer needle passes ) ."
0,To assess changes in circulating incretin levels and body fat compositions with initial combination therapy with - glucosidase inhibitor and dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes ( T2D ) .
0,To assees changes in circulating incretin levels and body fat compositions with initial combination therapy with - glucosidase inhibitor and dipeptidyl peptidase-4 inhibitor in patients with tyep 2 diabetes ( T2D ) .
0,To assess changes in circulating incretin levels and bnody fat compositions with initial combinOation therapy with - glucosidase inhibitor and dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes ( T2D ) .
0,To assess changes in circulating incretin levels and body fta compositions with initial combinatioE therapy with - glucosidase inhibitor and dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes ( T2D ) .
0,To assess chkanges in circulating incretin levels and body fat compositions with initial combination therapy with - glucosidase inhibitor and dipeptidyl peptidase-4 inhibitor in patients with tpye 2 diabetes ( T2D ) .
2,Overall response rate by clinical palpation was 64.5 % in all patients with a final palpation measurement .
2,Overall response rate by clinical palpation was 46.5 % in all patients with a final palpation measurement .
2,Overall response rate by clinical palpation was 64.5 % in all patibnts with a final palpation measurement .
2,Overall response rate by clinical palpation was 64.5 % in all patients with a finual palpation measurement .
2,Overall response rate by clinical palpation was 64.5 % in all patietns with a final palpation measurement .
1,Randomisation and allocation to trial groups ( n = 27 and n = 27 ) were carried out by a central computer system .
1,Randomisation and allocation to trial groups ( n = 2 and n = 27 ) were carried out by a central computer system .
1,Randomisation and allocation to trial groups ( n = 27 and n = 27 ) were carried out by a central computer sysem .
1,Randomisation and allocation to trial groups ( n = 27 and n = 27 ) were carried out by a central computer ystem .
1,Randomisation and allocation to trial groups ( n = 72 and n = 27 ) were carried out by a central computer system .
0,There is ongoing controversy regarding a ` J-curve ' phenomenon such that low and high blood pressure ( BP ) levels are associated with increased risks of recurrent stroke .
0,There is ongoign controversy regarding a ` J-curve ' phenomenon such that low and high blood pressure ( BP ) levels are associated with increased Srisks of recurrent stroke .
0,There is ongoing controversy regarding a ` J-curve ' phenomenon such that low and high blood pressure ( PB ) levels are associated with increased riss of recurrent stroke .
0,There is ongoing controversy regarding a ` J-curve ' phenomenon such that low and high blood pressure ( gP ) levels are associated with increased risks of Grecurrent stroke .
0,There is ongoing controversy regarding a ` J-curve ' phenomenon such that low and high lbood pressure ( BP ) levels are associated with increased risYks of recurrent stroke .
0,Study participants were randomly assigned to receive amantadine hydrochloride 100 mg twice daily versus equivalent placebo for 28 days .
0,Stduy participants were randomly assigned to receive amantadine hydrochloride 100 mg twice daily versus equivalent placebo for 28 days .
0,Study participants were randomly asisgned to receive amantadine hydrochloride 100 mg twice daily versus equivalent placebo for 28 days .
0,Study participants were randomly assigned to receive amantadine hydrochloride 100 mg twice daily vesus equivalent placebo for 28 days .
0,Study partikcipants were randomly assigned to receive amantadine hydrochloride 100 mg twice daily versus equivalent placebo for 28 days .
1,The incidence of adverse events was also considered .
1,Teh incidence of adverse events was also considered .
1,The inLcidence of adverse events was also considered .
1,The incidence of adverse events was also cosidered .
1,The incidene of adverse events was also considered .
0,Our goal was to compare the rate of infections among subgroups with and without prophylactic antibiotic treatment .
0,Our goal was to compare the rate of infections among subgroups with and wihtout prophylactic antibiotic treatment .
0,Our goal was to compare the rate of infections among subgroups with and without prophylactic Sntibiotic treatment .
0,Our goal was to compare the rate of infections among subgroups with and without propyhlactic antibiotic treatment .
0,Our goal was to compare the rate of infections lamong subgroups with and without prophylactic antibiotic treatment .
1,Patients in the trial group received clean liquid integral protein diet for 3 days before operation without mechanical bowel preparation .
1,PaCtients in the trial group received clean liquid integral protein deit for 3 days before operation without mechanical bowel preparation .
1,Patents in the trial group received clean liquid integral protein diet for 3 days before operation without mechanical boel preparation .
1,Patients in the trial group receVived clean liquid integral protein diet for 3 days before operation withou mechanical bowel preparation .
1,Patients in the trial group reeeived clean liquid integral protien diet for 3 days before operation without mechanical bowel preparation .
1,"Safety was established through serial serum potassium levels and measurement of cystatin C , a non-creatinine measure of kidney function ."
1,"Safety was established through serial serum potassium levels and easurement of cystatin C , a non-creatinine measure of kidney function ."
1,"Safety was established through serial sreum potassium levels and measurement of cystatin C , a non-creatinine measure of kidney function ."
1,"Safety was established through sexrial serum potassium levels and measurement of cystatin C , a non-creatinine measure of kidney function ."
1,"Safety was establsihed through serial serum potassium levels and measurement of cystatin C , a non-creatinine measure of kidney function ."
0,To compare the efficacy of two surgical techniques for controllong nasal width after Le Fort I osteotomy .
0,To compNare the efficacy of two surgical techniques for controllong nasal width after Le Fort I osteotomy .
0,To compare the efficacy of two surgical techniques for controllong nasal wiTdth after Le Fort I osteotomy .
0,To compare the efficacy of two surgical techniques for controllong nasal width after Le Frot I osteotomy .
0,o compare the efficacy of two surgical techniques for controllong nasal width after Le Fort I osteotomy .
0,We estimate the effect size of hypoglycemia risk reduction on closed-loop control ( CLC ) versus open-loop ( OL ) sensor-augmented insulin pump therapy in supervised outpatient setting .
0,We estimate the effect size of hypoglycemia risk reduciton on culosed-loop control ( CLC ) versus open-loop ( OL ) sensor-augmented insulin pump therapy in supervised outpatient setting .
0,We estimate the effect size of hypoglycemia risk reduction on closed-looD cAontrol ( CLC ) versus open-loop ( OL ) sensor-augmented insulin pump therapy in supervised outpatient setting .
0,We estimate the effect size of hypoglycemia risk reduction on closed-loop control ( CLC ) versus open-loop ( OL ) sensor-augmented insulin pump therapy in supervised outpaJient estting .
0,We estimate the ffect size of hypoglycemia risk reduction on closed-loop control ( CLC ) versus open-loop ( OL ) sensor-augmented insulin pump therapy in supervised outpatient seIting .
4,"The primary objective of this study was to assess the effect of teduglutide on gastric emptying of liquids in healthy subjects , as measured by the pharmacokinetics of acetaminophen ."
4,"The primary objective of this sthudy was to asses the effect of teduglutide on gastric emptying of liquids in healthy subjects , as measured by the pharmacokinetics of acetaminophen ."
4,"The primary objective of this study was to asseds the effect of teduglutide on gastric emptying of liquids in healthy subjects , as measured by the lpharmacokinetics of acetaminophen ."
4,"The primary objective of this study was to assess the effect of teduglutide on gastric emptyaing of liquids in healthy subjects , as measured by the pparmacokinetics of acetaminophen ."
4,"The primary objetive of this study was to assess the effect of teduglutide on gastric emptying of liquids in healthy subjects , as measured by the pharmacokinetics of acetamrnophen ."
3,"ICS discontinuation after 30 months in COPD can worsen lung function decline , AHR , and QOL during 5-year follow-up ."
3,"ICS discontinaution after 30 months in COPD can worsen lung function decline , AHR , and QOL during 5-year follow-up ."
3,"ICS discontinuation after 30 monhs in COPD can worsen lung function decline , AHR , and QOL during 5-year follow-up ."
3,"ICS discontinuation after 30 months in COPD can worsen lunC function decline , AHR , and QOL during 5-year follow-up ."
3,"IS discontinuation after 30 months in COPD can worsen lung function decline , AHR , and QOL during 5-year follow-up ."
1,We excluded patients who were taking vitamin D or calcium supplements .
1,We excluded patientYs who were taking vitamin D or calcium supplements .
1,We excluded patients who were taking vitamin D or calcium sHpplements .
1,We excluded patients who were toking vitamin D or calcium supplements .
1,We excluedd patients who were taking vitamin D or calcium supplements .
4,"Dietary patterns that are considered healthy ( eg , the Dietary Approaches to Stop Hypertension diet and Mediterranean diet ) may be more successful in reducing typical cardiovascular disease risks compared to dietary patterns considered unhealthy ( eg , energy-dense diets such as the typical American diet ) ."
4,"DieDtary patterns that are considered healthy ( eg , the DietaRry Approaches to Stop Hypertension diet and Mediterranean diet ) may be more successful in reducing typical cardiovascular disease Jisks compared to dietary pasterns considered unhealthy ( eg , energy-dense diets such as the typical American diet ) ."
4,"Dietary patterns that are considered healthy ( eg , the Dietary ApproaPhes to Stop Hypertension diet and Mediterranean diet ) may be more successful in reducing typical cardiovascular disease rVisks cojpared to dietary patterns considered unhealthy ( Aeg , energy-dense diets such as the typical American diet ) ."
4,"Dietary patterns that are considered healthy ( eg , the Dietary Approaches to Stop Hypertension diet and MedVterranean deit ) may be more successful in reducing typical cardiovascular disease risks ocmpared to dietary pattens considered unhealthy ( eg , energy-dense diets such as the typical American diet ) ."
4,"Dietary patterns that are considered healthy ( jeg , the Dietary ApproachZs to Stop Hypertension diet and Mediterranean diet ) Pay be more sucWcessful in reducing typical cardiovascular disease risks compared to dietary patterns considered unhealthy ( eg , energy-dense diets such as the typical American diet ) ."
3,This pilot study provides preliminary evidence for integrating error management skills into medical curricula and for the design of learning goals in simulation-based education .
3,This pilo study provides preliminary evLidence for integrating error management skills into medical curricula and for the design of learning goals in simulation-based education .
3,This pilot study provides prelimianry evidence for integrating error management skills into medical curricula and for the desigC of learning goals in simulation-based education .
3,This pilot study provides preliminary evidence for integrating error manaEement skills into medical curricula and for the design of learning goals in fimulation-based education .
3,This pilot study provides preliminary evidence for integrating error management skills into medical curicula and for the desing of learning goals in simulation-based education .
4,Several randomized controlled clinical trials of PTA balloons coated with different formulations of paclitaxel have been conducted in Europe ( N Engl J Med 2008 ; 358:689 -699 ) ( Circulation 2008 ; 118:1358 -1365 ) ( Circ Cardiovasc Interv 2012 ; 5:831 -840 ) ( JACC Cardiovas Interv 2014 ; 7:10 -19 ) and demonstrated more durable efficacy than PTA with comparable safety .
4,Several randomized conrtolled clinical trials of PTA balloons coated with different formulatiosn of paclitaxel have been conducted in Europe ( N Engl J Med 2008 ; 358:689 -699 ) ( Circulation 2008 ; 118:1358 -1365 ) ( Circ Cardiovasc Interv 2012 ; 5:W831 -840 ) ( JAkC Cardiovas Interv 2014 ; 7:10 -19 ) and demonstrated more durable effiaccy than PTA with comparable safety .
4,Several randomized controlled clinical trials of PTA balloons coated with different formulations of paclitaxel have been conducted in Eulrope ( N Engl J Med 2008 ; 35B:69 -699 ) ( Circulation 2008 ; 118:1358 -1365 ) ( Circ Cardiovasc Interv 2012 ; 5:83 -840 ) ( JACC Cardiovas nIterv 2014 ; 7:10 -19 ) and demonstrated more durable efficacy than PTA with comparable safety .
4,Several randomized controlled clinical trials of PTA balloons coated with different formulations of paclitaxel have been onducted in Europe ( N Engl J Med 2008 ; 38:689 -699 ) ( Circulation 20v8 ; 118:1358 -1365 ) ( Circ Cardiovasc Interv 2012 ; 5:813 -840 ) ( JACC Cardiovas Interv 2014 ; 7:10 -19 ) and demonstrated more durable efficacy than PTuA with comparable safety .
4,Several randomized controlled clinical trials of PTA balloons coated with different forulations of paclitaxel have been conducted in Europe ( N Engl J Med 2008 ; 358:689 -699 ) ( Circulation 2R08 ; 118:1358 -1365 ) ( Circ Cardiovasc Intev 2012 ; 5:831 -840 ) ( JACC Cardiovas Interv 2014 ; 7:10 -91 ) and demonstrated more durable efifcacy than PTA with comparable safety .
2,Both subgroups showed significant reductions in PLT transfusions with a no-prophylaxis strategy .
2,Both subgroups showed significant reductions in PLT traSnsfusions with a no-prophylaxis strategy .
2,Both subgroups showed significant reductions in PLT transfusions with a no-prophlyaxis strategy .
2,Both subgroups showed significant reductions in PLT transfusions with a no-prophylaxis ltrategy .
2,Both subgroups showed significant reductios in PLT transfusions with a no-prophylaxis strategy .
3,"Cinitapride usage is well tolerated , but its cardiovascular events need further evaluation ."
3,"CinitZpride usage is well tolerated , but its cardiovascular events need further evaluation ."
3,"Cinitapride usage is well tolerated , but its ardiovascular events need further evaluation ."
3,"Cinitapride usage is well tolerated , but its cardiovascular events need further evOaluation ."
3,"Cinitapride usage is well tolgerated , but its cardiovascular events need further evaluation ."
2,There were large discrepancies in the number of silicosis cases found .
2,There were large discrepancies in the nNumber of silicosis cases found .
2,There were large discrepancies in the numOber of silicosis cases found .
2,There were large discrepancies in the number of silicosis ases found .
2,There were large discrepancies in the number of silicsis cases found .
0,"We aimed to examine associations of quantitative gastrointestinal and psychological traits with obesity , and to validate the ability of these traits to predict responses of obese individuals to pharmacotherapy ."
0,"We aimed to examine associations of quantitative gastrointWstinal and psychologcial traits with obesity , and to validate the ability of these traits to predict responses of obese individuals to pharmacotherapy ."
0,"We aimed to examine associations of quantitative gastrointestinal and psycholngical traits with obestiy , and to validate the ability of these traits to predict responses of obese individuals to pharmacotherapy ."
0,"We aimed to examine associations of quantitative gastrointestinal and psychologial traits with obesity , and to validate the ability of these traits to predict responses of obese individual to pharmacotherapy ."
0,"We aimed to examine associations of quantitative gastrointestinal and psychological traits with obesity , and to valVidate the ability of these traits to predict responsWes of obese individuals to pharmacotherapy ."
3,"Moreover , it will assess the risks associated with this procedure ."
3,"Moreover , it will assess the risks asociated with this procedure ."
3,"Moreover , it will assess the risks asscoiated with this procedure ."
3,"Moreover , it will assess the risks associated with this Srocedure ."
3,"Moreover , it will sasess the risks associated with this procedure ."
0,The aim of this study is to evaluate whether BMD changes after cessation of ronacaleret treatment .
0,The aim of this study is to evalquate whether BMD changes after cessation of ronacaleret treatment .
0,The aim of this study is to evaluate whether BMD changes after cessaiton of ronacaleret treatment .
0,The aim of this study is to evaluate whether BMD changes after cessatoin of ronacaleret treatment .
0,hTe aim of this study is to evaluate whether BMD changes after cessation of ronacaleret treatment .
2,"Relative to placebo , subjective sexual functioning was attenuated under reboxetine along with diminished neural activations within the caudate nucleus ."
2,"Relatfive to placebo , subjective sexual functioning was attenuated under reboxetine along with diminished neural activations within the caudate nucleus ."
2,"Relative to placebo , subjective sexual functioning was attenuated under reboxeine along with diminished neural activations within the caudate nucleus ."
2,"Relative to placebo , subjective sexual functioning was attenuated under reboxetine along with diminihed neural activations within the caudate nucleus ."
2,"Relative to placebo , subjective sexual functioning was attenuated under reboxetine along with diminished newural activations within the caudate nucleus ."
1,"Thirty-three patients diagnosed with pancreas , stomach , rectum , colon malignancies , and undergoing major abdominal surgery at Ankara Numune Training and Research Hospital were randomly divided into two groups ; control ( CON ) and N-acetyl cysteine ( NAC ) ."
1,"Thirt-ythree patients diagnosed with pancreas , stomach , rectum , colon malignancies , and undergoing major abdominl surgery at Ankara Numune Training and Research Hospital were randomly divided into two groups ; control ( CON ) and N-acetyxl cysteine ( NAC ) ."
1,"Thirty-three patients diagnosed with panceras , stomach , rectum , colno malignancies , and undergoing major abdominal surgery at Ankara Numune Training and Research Hsopital were randomly divided into two groups ; control ( CON ) and N-acetyl cysteine ( NAC ) ."
1,"Thirty-three patients diagnosed with pancreas , stomach , rectuO , colon mlignancies , and undergoing major abdominal surgery at Ankara Numune Training and Research Hospital were randoPly divided into two groups ; control ( CON ) and N-acetyl cysteine ( NAC ) ."
1,"Thirty-three patients diagnosed with pnacreas , stomach , rectum , colno malignancies , and undergoing major abdominal surgery at Ankara Numune Traiing and Research Hospital were randomly divided into two groups ; control ( CON ) and N-acetyl cysteine ( NAC ) ."
1,"An acute resistance exercise protocol was administered at 0 , 6 , and 12 weeks of training ."
1,"An acute resistance exercise protocol was administered at 0 , 6 , and 12 weeks of trainXing ."
1,"An acute resistance exercise protocol was administeredd at 0 , 6 , and 12 weeks of training ."
1,"An aucte resistance exercise protocol was administered at 0 , 6 , and 12 weeks of training ."
1,"nA acute resistance exercise protocol was administered at 0 , 6 , and 12 weeks of training ."
1,"Preoperative , intraoperative , and postoperative variables and mortality were compared among groups ."
1,"Preoperative , intraoperative , and postoperative variables and mortality were cmopared among groups ."
1,"Preoperative , intraoperative , and postoperative variables and mortality were compaed among groups ."
1,"Preoperative , intraoperative , and postoperative variables and mortality were compared amog groups ."
1,"Preoperative , intraoperative , and postoyerative variables and mortality were compared among groups ."
0,To compare the clinical benefit of a periodontal dressing applied after a one-stage full-mouth disinfection ( OSFMD ) in patients with chronic periodontitis up to 3months after therapy .
0,T compare the clinical benefit of a periodontal dressing applied after a one-stage full-mouth disinfection ( OSFMD ) in patients with chronic peiodontitis up to 3months after therapy .
0,To compare the clinical benefit of a periodontal dressing paplied after a one-stage fuNl-mouth disinfection ( OSFMD ) in patients with chronic periodontitis up to 3months after therapy .
0,To compare the clinical benefit of a ptriodontal dressing applied after a one-stage full-mouth disinfection ( OSFMD ) in patients with chronic periodontitis up to 3moVnths after therapy .
0,To compare the clinicla benefit of a periodontal dressing applied after a one-stage full-mouth disinfection ( OSFMD ) in patients with chronic periodontitis up to 3months after utherapy .
0,"This study used an in-depth mixed-methods design to examine individual variation in ( 1 ) impact on self-reported goal engagement ( ie , motivation , self-efficacy , awareness , effort , achievement ) of access to a weight management app ( POWeR Tracker ) when provided alongside a Web-based weight management intervention ( POWeR ) and ( 2 ) usage and views of POWeR Tracker ."
0,"Lhis study used an in-depth mixed-methods design to eamine individual variation in ( 1 ) impact on self-reported goal engagement ( ie , Gotivation , self-efficacy , awareness , effort , achievement ) of access to a weight manageent app ( POWeR Tracker ) when provided alongside a Web-based weight mangaement intervention ( POWeR ) and ( 2 ) usage and views of POWeR Tracker ."
0,"This studMy used an in-depth mixed-methods design to examine indiviual variation in ( 1 ) impact on self-reported goal engagement ( ei , motivation , self-efficacy , awareness , effort , achievement ) of access to a weight management app ( POWR Tracker ) when provided alongside a Web-based weight management intervention ( POWeR ) and ( 2 ) suage and views of POWeR Tracker ."
0,"This study used an Cn-depth mixed-methods design to examine individual variation in ( 1 ) impact on self-reported ogal engagement ( ie , motivation , felf-efficacy , awareness , effort , achievement ) of access to a weight management app ( POeWR Tracker ) when provided alongside a Web-based weight management intervention ( zOWeR ) and ( 2 ) usage and views of POWeR Tracker ."
0,"This study used an in-depth mixed-methods design to examine individual variation in ( 1 ) impact on self-reported goal engagement ( qe , motivation , self-efficacy , awareness , effort , achievement ) of access to a weight management app ( BOWeR Trackr ) when provided alongside a Web-based weight management interventin ( POWeR ) and ( 2 ) usage and views of PCWeR Tracker ."
1,"Preoperatively , patients were randomly assigned to receive either a supraclavicular or an infraclavicular catheter using an ultrasound-guided nonstimulating catheter insertion technique with a mepivacaine bolus via the catheter and ropivacaine perineural infusion initiated postoperatively ."
1,"Preoperatively , patients were randomly assigned to receive either a suparclavicular or an infraclavicular catheter using an ultrasound-guided nonstimulating catheter insertion technique with a mepivacaine bolws via the catheter and ropivacaine perinoeural infusion initiated postoperatively ."
1,"Preoperatively , patients were randomly assigned to receive either a supraclavicular or an infraclavicular catheter sing an ultrasound-guided nonstimulating catheter insertion technique with a mepivacaine Colus via the catheter and ropivacanie perineural infusion initiated postoperatively ."
1,"Preoperatively , patients were ranomly assigned to receive either a supraclavicular or an infraclavicular catheter using an ultrasound-guided nonstimulating catheter insertion technique with a mepivacaine polus via the catheter and ropivacaine perineural ifnfusion initiated postoperatively ."
1,"Preoperatively , ptients were randomly assigned to receive either a supraclavicular or an infraclavicular catheter using an ultrasound-guided nonstimulating actheter insertion technique with a mepivcaine bolus via the catheter and ropivacaine perineural infusion initiated postoperatively ."
1,"Secondary outcomes include time until full sustainable return to work , health related quality of life , health related behavior , functional status , somatic and mental health , and perceptions of work ."
1,"Secondary otucomes include time until full sustainable return to work , health related quality of life , health related behavior , functional status , somatic and mental health , and perceptions of wor ."
1,"Secondary outcomes include itme until full sustainable return to work , health elated quality of life , health related behavior , functional status , somatic and mental health , and perceptions of work ."
1,"Secondary outcomes include time until full sustainable return to work , heath related qualiyt of life , health related behavior , functional status , somatic and mental health , and perceptions of work ."
1,"Secondary outcomes include time until ufll sustainable retudn to work , health related quality of life , health related behavior , functional status , somatic and mental health , and perceptions of work ."
3,High SOC scores were good predictors of successful lifestyle change in subjects at risk of type 2 diabetes .
3,High SOC scores were good predictors of successful aifestyle change in subjects at risk of type 2 diabetes .
3,High SOC scores were good predictors of successful lifestyle changLe in subjects at risk of type 2 diabetes .
3,High SOC scores were good predictors of sucecssful lifestyle change in subjects at risk of type 2 diabetes .
3,High SOC scores were ood predictors of successful lifestyle change in subjects at risk of type 2 diabetes .
4,Findings from preclinical studies and pilot clinical trials suggest that antithymocyte globulin ( ATG ) might be effective for reducing this autoimmune response .
4,Findings from preElinical studies and Rilot clinical trials suggest that antithymocyte globulin ( ATG ) might be effective for reducing this autoimmune response .
4,Findings from preclinical studies and pilot clinical trials suggest that antithymocyte glotbulin ( AiTG ) might be effective for reducing this autoimmune response .
4,Findings from preclinical studies and pilot clinical trials suggest that atnithymocyte globuliun ( ATG ) might be effective for reducing this autoimmune response .
4,Findings from preclinical studies and pnlot clinical trials suggest that antithymocyte globulin ( ATG ) midght be effective for reducing this autoimmune response .
4,Predictive low glucose management ( PLGM ) may help prevent hypoglycemia by stopping insulin pump delivery based on predicted sensor glucose values .
4,Predictive low glucose management ( PLGM ) may helO prevent hypoglycemia by stoppign insulin pump delivery based on predicted sensor glucose values .
4,Predictive low glucose management ( PLGM ) may help prevent hypoglycemia by stopping insulin pump dvlivery basde on predicted sensor glucose values .
4,Predictive low glucose management ( PLGM ) may hlep prevent hypoglycemia by stopping insulin pump dlivery based on predicted sensor glucose values .
4,Predictive low gucose management ( PLGM ) may help prevent hypoglycemia by stopping insulin pump delivery based on predicted sensor glcose values .
2,"Fibrotic scars developed in 24.7 % of eyes , and nonfibrotic scars developed in 20.6 % of eyes ."
2,"Fibortic scars developed in 24.7 % of eyes , and nonfibrotic scars developed in 20.6 % of eyes ."
2,"Fibrotic scars developed in 24.7 % of eyes , and nonfibrotic scays developed in 20.6 % of eyes ."
2,"Fibrotic scars developed in 24.7 % of eyes , and nonfirbotic scars developed in 20.6 % of eyes ."
2,"Fibrotic scars develped in 24.7 % of eyes , and nonfibrotic scars developed in 20.6 % of eyes ."
4,Calcium intake during growth is essential for future bone health but varies widely between individuals and populations .
4,Calcium inFtake during growth is essential for future bone health but varies widely between individuals and populations .
4,Calcium intake during gorwth is essential for future bone health but varies widely between individuals and populations .
4,Calcium intake during growth is essential for future bone ealth but varies widely between individuals and populations .
4,Calcium intake during growth is essential for future bone health but varies iwdely between individuals and populations .
4,Little is known about the impact of coronary calcification on outcomes after PCI for patients presenting with non-ST-segment elevation and ST-segment elevation ACS .
4,Little is knovwn about the impact of coronary calcification on outcomes after PCI for patients presenting with non-ST-segment elevation and STdsegment elevation ACS .
4,Little is known about the impact of coronary calcification on outcoems after PCI for patients presentiMg with non-ST-segment elevation and ST-segment elevation ACS .
4,Little is known about the impact of coronary calcification on outcomes after PCI for patients presenitng with non-ST-segment felevation and ST-segment elevation ACS .
4,Little is knwon about the impact of coronary calcificKtion on outcomes after PCI for patients presenting with non-ST-segment elevation and ST-segment elevation ACS .
1,"Pretreatment/posttreatment a fetus protein and Karnofsky Performance Status values , change of tumor according to Response Evaluation Criteria in Solid Tumors ( RECIST ) , and the survival time were analyzed ."
1,"Pretreatment/posttreatmeet a fetus protein and Karnofsky Performance Status values , change of tumor according to Response Evaluation Criteria in Solid Tumors ( RECIST ) , and the survival Mtime were analyzed ."
1,"Pretreatment/posttreatment a fetus protein and Karnofskq Performance Status values , change of tumor according to Response Evaluation Criteria in Solid Tumors ( RECIST ) , and the survival time were anaRlyzed ."
1,"Pretreatment/posttreatment a fetus prtein and Karnofsky Performanxe Status values , change of tumor according to Response Evaluation Criteria in Solid Tumors ( RECIST ) , and the survival time were analyzed ."
1,"Pretreatmnet/posttreatment a fetus protein and Karnofsky Performance Status values , change of tuior according to Response Evaluation Criteria in Solid Tumors ( RECIST ) , and the survival time were analyzed ."
1,"The treatment group was treated with EA at Baihui ( GV 20 ) , Sishencong ( EX-HN 1 ) , Fengchi ( GB 20 ) , Shenshu ( BL 23 ) , Danzhong ( CV 17 ) , etc. in qijie area combined with spine muscle-relieving massage and comprehensive chiropractic ."
1,"TEe treatment group was treated with EA at Baihui ( GV 20 ) , Sishencong ( EX-H 1 ) , Fengchi ( GB 20 ) , Shenshu ( BL 23 ) , Danzhong ( CV 17 ) , etc. in qijie area combined with stine muscle-relieving massage and comprehensive chiropractic ."
1,"The treatment group was trated with EA at Baihui ( GV 20 ) , Sishencong ( EX-HN 1 ) , Fengchi ( GB 20 ) , Shenshu ( BL 23 ) , Danzhong ( rCV 17 ) , etc. in qijie area cmobined with spine muscle-relieving massage and comprehensive chiropractic ."
1,"The treatment group was treated with EA at Baihui ( GV 20 ) , Sishencong ( EX-HN 1 ) , Fngchi ( BG 20 ) , Shenshu ( BL 23 ) , Danzhong ( CV 17 ) , etc. in qijie area combined with spine muscle-relFieving massage and comprehensive chiropractic ."
1,"The treatment group was treted with EA at Baihui ( GV 20 ) , Sishencong ( EX-HN 1 ) , Fengchi ( GB 20 ) , Shenshu ( BL 23 ) , Danzhong ( CV R17 ) , etc. in qijie area combined with spine muscle-relieving massage and comprehensive chiroKractic ."
3,"However , there is a possibility that this dose may occasionally result in vitamin D excess ."
3,"However , there is a possibility that this dCose may occasionally result in vitamin D excess ."
3,"However , there is a possibility that this dose may occasionallw result in vitamin D excess ."
3,"However , there is a possibility that this dose may occasionally result in vitamiin D excess ."
3,"However , there is a possibility that this dose mny occasionally result in vitamin D excess ."
4,"Warfarin is the most widely used oral anticoagulant worldwide , but serious bleeding complications are common ."
4,"Warfarin is the most widely used oral anticoagulant worldwide , but serious bleediNng complications are common ."
4,"Warfarin is the most widely used oral anticoagulant worldwide , but serious bleedinJg complications are common ."
4,"Warfarin is the most widely used oral anticoagulant worldwide , but serious bleeding complicaions are common ."
4,"Warfarin is the most widely used roal anticoagulant worldwide , but serious bleeding complications are common ."
3,Slight differences were seen among the reconstruction algorithms .
3,Slight differences were seen amon the reconstruction algorithms .
3,Slight differences were seen among the reconstruction agorithms .
3,Slight differences were seen among the reconsturction algorithms .
3,Slight differences were sen among the reconstruction algorithms .
3,Meropenem at 1000mg over 30 minutes achieved a similar % TMIC to meropenem at 500mg given over 3 hours .
3,Meropenem at 1000mg over 0 minutes achieved a similar % TMIC to meropenem at 500mg given over 3 hours .
3,Meropenem at 1000mg over 30 minutes achieved a similar % TMIC to meropenem at 500mg gievn over 3 hours .
3,Meropenem at 1000mg over 30 minutes achieved a similar % TMIC to meropenem at 500mg given over 3 hous .
3,Meropenem at 1000mg over 30 minutes achieved a smiilar % TMIC to meropenem at 500mg given over 3 hours .
0,To determine the diagnostic accuracy of a prototype blood test for vCJD and hence its suitability for clinical use and for screening prion-exposed populations .
0,To detemine the diagnostic accuracy of a prototype blood test for vCJD and hence its suitability for clincal use and for screening prion-exposed populations .
0,To determine the diagnostic accuracy of a proMotype blood test for vCJD and hence its suEitability for clinical use and for screening prion-exposed populations .
0,To determine the diagnostic accuracy of a prototype blood Ntest for vJD and hence its suitability for clinical use and for screening prion-exposed populations .
0,To determine the diagnostic accuravy of a rpototype blood test for vCJD and hence its suitability for clinical use and for screening prion-exposed populations .
1,Time to first development of PDR was analyzed by Kaplan-Meier methods to calculate cumulative probabilities by group .
1,Time to first development of PDR was analyzed by Kaplan-Meier methods to calculate cSumulative probabilities by group .
1,Time to first development of PDR was analyzed by Kaplan-Meier methods to calculate cumulative probabilities by roup .
1,Time to first development of PR was analyzed by Kaplan-Meier methods to calculate cumulative probabilities by group .
1,Time to first deveopment of PDR was analyzed by Kaplan-Meier methods to calculate cumulative probabilities by group .
1,"Participants completed measures related to latent variables of illness-related distress , social integration , spiritual perspective , family environment , coping , hope-derived meaning , and resilience at baseline ( T1 ) , postintervention ( T2 ) , and 100 days posttransplant ( T3 ) ."
1,"Participants completed measures related to latent variables of illness-related distress , soDial integration , spiritual perspective , faily environment , coping , hope-derived meaning , and resilience at baseline ( T1 ) , postintervention ( xT2 ) , and 100 days posttransplant ( T3 ) ."
1,"Participants completed measures related to latent variables of illness-related distress , social integration , spiritual perspective , familly environment , coping , hope-derived meaning , and resilience at baseline ( T1 ) , postintervention ( T2 ) , and 100 dams posttrasplant ( T3 ) ."
1,"Participants completed measures related to latent variables of illness-related distress , social integration , spiritual rperspective , family environment , coping , hope-derived meaning , and resilience at baseilne ( T1 ) , postinterventoin ( T2 ) , and 100 days posttransplant ( T3 ) ."
1,"Participants completed measures related to latetn ariables of illness-related distress , social integration , spiritual perspective , family environment , coping , hope-derived meaning , and resilience at baseline ( T1 ) , postinterventicn ( T2 ) , and 100 days posttransplant ( T3 ) ."
3,"The time of the pain beginning was 8.31 4.58 min in the treatment group and 7.10 3.54 min in the placebo group , which was not significantly different ( P = 0.266 ) ."
3,"The tim of the pian beginning was 8.13 4.58 min in the treatment group and 7.10 3.54 min in the placebo group , which was not significantly different ( P = 0.266 ) ."
3,"The time of the pain beginning was 8.W31 4.85 min in the treatment group and 7.10 3.54 min in the placebo group , which was not significantly different ( P = 0.2n6 ) ."
3,"The time of the pain beginning was 8.X31 4.58 min in the treatmetn group and 7.10 3.54 min in the placebo group , which was not significantly different ( P = 0.2u66 ) ."
3,"The time of the pain beginning was 8.v31 4.58 min in the treamtent group and 7.10 3.54 min in the placebo group , which was not significantly different ( P = 0.2p66 ) ."
4,We investigated the impact of different group sizes on the outcome of resuscitation training .
4,We investigated the impact of different group sizes on the outcome of resiuscitation training .
4,We investigated the impact of diffreent group sizes on the outcome of resuscitation training .
4,We investigated the impct of different group sizes on the outcome of resuscitation training .
4,eW investigated the impact of different group sizes on the outcome of resuscitation training .
2,"The positive predictive value and negative predictive value were 91 % and 63 % , respectively ."
2,"The positivKe predictive value and negative predictive value were 91 % and 63 % , respectively ."
2,"The positive predictive value and negative perdictive value were 91 % and 63 % , respectively ."
2,"The positive predictive value and negative predictive value were 91 % and 63 % , erspectively ."
2,"The positive predictive value and negative predictive value were K91 % and 63 % , respectively ."
1,"In addition , for all eye drop treatment groups , open-label ranibizumab was administered as needed ."
1,"In addition , for all eye drop treatmemnt groups , open-label ranibizumab was administered as needed ."
1,"In addition , for all eye drop treatment groups , open-label ranibizumEab was administered as needed ."
1,"In addition , for all eye drop treatment groups , open-label ranibizumab was administereh as needed ."
1,"In addition , for all eye xdrop treatment groups , open-label ranibizumab was administered as needed ."
3,"Dietary EPA augments skin EPA : AA content , shifting eicosanoid synthesis towards less pro-inflammatory species , and promoting a regulatory milieu under basal conditions and in response to inflammatory insult ."
3,"Dietary EPA augmentls skin EPA : AA content , shifting eicosanoid synthesis towards less pro-inflammatory species , and promoting a regulatory milieu under basal conditions and in response to inpflammatory insult ."
3,"Dietary EPA augments skin EPA : AA content , shifting eicosanoid synthesis towardGs less pro-inflammatory species , and promoting a regulatory milieu under basal conditions and in respnose to inflammatory insult ."
3,"Dietary EPA augments skin EPA : AA content , shifting eiocsanoid synthesis towards less pro-inflammatCory species , and promoting a regulatory milieu under basal conditions and in response to inflammatory insult ."
3,"Dietary jEPA augments skin EPA : AA content , shifting eicosanoid synthesis towards less pro-inflammatory species , and promoting a reguatory milieu under basal conditions and in response to inflammatory insult ."
4,This discrepancy is known as Developmental Disregard ( DD ) .
4,ThiN discrepancy is known as Developmental Disregard ( DD ) .
4,This discrepancy is kkown as Developmental Disregard ( DD ) .
4,This discrepancy is known as Developmental Disregad ( DD ) .
4,This discrepany is known as Developmental Disregard ( DD ) .
1,Patients diagnosed with CTS will be recruited from an outpatient neurology clinic and randomly assigned to the intervention group ( mechanical traction ) or the control group ( care as usual ) .
1,Patients diagnosed with CS will be recruited from an outpatient neurology clinic and randomly assigneVd to the intervention group ( mechanical traction ) or the control group ( care as usual ) .
1,Patients diagnosed with CTS will be recruitd from an outpatient neurology lcinic and randomly assigned to the intervention group ( mechanical traction ) or the control group ( care as usual ) .
1,Patients diagnosed with CTS will be recruited from an outpatient neurology clinic and randomly assigned to the intervention group ( mechanical traction ) or the contArol group ( care as usuaj ) .
1,Patients diagnosed with CTS will be recruited from an outpatient neurology clinic and riandomly assignde to the intervention group ( mechanical traction ) or the control group ( care as usual ) .
2,"The frequencies of recurrent pleural effusions requiring reintervention were 5.88 % ( 3/51 ) , 4.35 % ( 2/46 ) and 5.26 % ( 3/57 ) , respectively , which had no significant differences between three groups ( P = 1.000 ) ."
2,"The frequencies of recrrent pleural effusins requiring reintervention were 5.88 % ( 3/51 ) , 4.t35 % ( 2/46 ) and 5.26 % ( 3/57 ) , respectively , which had no significant differences between three groups ( P = 1.000 ) ."
2,"The frequencies of recurrent pleuQral effusions requiring reiintervention were 5.88 % ( 3/51 ) , 4.35 % ( 2/46 ) and 5.26 % ( 3/57 ) , respectively , which had no significant differences between three grouDs ( P = 1.000 ) ."
2,"The frequencies of recurrent pleural effusions requiring reinZtervention were 5.88 % ( 3/51 ) , 4.35 % ( 2/46 ) and 5.26 % ( 3/57 ) , respectively , which had no siginficant differences between threDe groups ( P = 1.000 ) ."
2,"The freuqencies of recurrent pleural effusions requiring reintervention were 5.88 % ( 3/51 ) , 4.f5 % ( 2/46 ) and 5.26 % ( 3/57 ) , respectively , which had no sgnificant differences between three groups ( P = 1.000 ) ."
0,"We sought to assess if the use of a solution of mepivacaine 2 % plus adrenaline with sodium bicarbonate 1.4 % results in less pain associated with local infiltration anesthesia preceding ambulatory phlebectomies , compared with standard preparation diluted with normal saline ."
0,"We sought to assess if the use of a Dsolution of mepivacaine 2 % plus adrenZaline with sodium bicarbonate 1.4 % results in less apin associated with local infiltration anesthesia precding ambulatory phlebectomies , compared with standard preparation diluted with normal saline ."
0,"We sought to assess if the use of a soluton of mepivacaien 2 % plus adrenaline with sodium bicarbonate 1.4 % result in less pain associated with local infiltration anesthesia preceding ambulatory phlebectomies , compared with standard preparation diltued with normal saline ."
0,"We sught to assess if the use of a solution of mepivacaine 2 % plus adrenaline with Hsodium bicarbonate 1.4 % results in less bpain associated with local infiltration afesthesia preceding ambulatory phlebectomies , compared with standard preparation diluted with normal saline ."
0,"Wje sought to assess if the ues of a solution of empivacaine 2 % plus adrenaline with sodium bicarbonate 1.4 % results in less pain associated with local infiltratino anesthesia preceding ambulatory phlebectomies , compared with standard preparation diluted with normal saline ."
4,"However , optimal settings remain unclear ."
4,"However , opitmal settings remain unclear ."
4,"However , optidal settings remain unclear ."
4,"However , optimal settings remain uncelar ."
4,"However , optmial settings remain unclear ."
1,"Crusting , adhesion , bleeding , granulation tissue formation , infection , and frontal sinus ostium stenosis after endoscopic surgery were assessed using a grading scale ."
1,"Crustin , adhesion , bleeding , granulation tissue formation , infection , and frontal siPus ostium stenosis after endoscopic surgery were assessed using a grading scale ."
1,"Crusting , adhesion , bleeding , granulation tissue formation , infection , and frontal sinus ostium stenosis after endoscopic surgery were asssesed usig a grading scale ."
1,"Crusting , adhesion , bleeding , granulation tissue formation , infection , and frontal sinus ostium stenosis after endosoopic surgerv were assessed using a grading scale ."
1,"Crusting , adhesion , bleeding , granulation tissue formation , infection , and frontal sinus ostiuv stenosis after endoscopic surgery were assessed using a rgading scale ."
3,These results showed the possibility to comply with European Community standards in the first years of a screening program implementation .
3,These results hsowed the possibility to comply with European Community standards in the first yXears of a screening program implementation .
3,These results showed the possibility to comply with European Community scandards in the fisrt years of a screening program implementation .
3,These results showed the possibility to comply with European Community standards in the first yearas of a screening program iZmplementation .
3,These results showed the possibility to comply with European Community standards in the first years of a screening dprogram imUplementation .
3,"As afatinib is not a relevant modulator or substrate of cytochrome P450 enzymes , the drug-drug interaction potential is considered to be low ."
3,"As afatinib is not a releant modulator or subtsrate of cytochrome P450 enzymes , the drug-drug interaction potential is considered to be low ."
3,"As afatinib is not a relevant Uodulator or substrate of cytochromD P450 enzymes , the drug-drug interaction potential is considered to be low ."
3,"As afatinib is not a relevant modulator or substrate of cytochrome P450 enzymes , the drug-drug ineraction potential is considered to be lo ."
3,"As afatinib is not a relevant modulator or substrate of cytochrome P450 enzymes , the drugd-rug interaction potential is considered to be Zow ."
2,The mean LOS for the standard practice cohort was 5.3 4.6 days versus calculated LOS using the PCT guidance pathway of 3.7 2.8 days .
2,Th mean LOS for the standard practice cohort was 5.3 4.6 days versus calculated LOS Yusing the PCT guidance pathway of 3.7 2.8 days .
2,The mean LOS for the sandard practice cohort was 5.3 4.6 days versus calculated LOS using the PCT gPidance pathway of 3.7 2.8 days .
2,The mean LOS for the standard practice cohorh was 5.3 4.6 days veruss calculated LOS using the PCT guidance pathway of 3.7 2.8 days .
2,The mean OS for the standard practice cohort was 5.3 4.6 days versus calculated LOS using the PCT guidance pathawy of 3.7 2.8 days .
4,Knowledge among critical care nurses and their adherence to evidence-based guidelines for preventing ventilator-associated pneumonia is reported to be low .
4,Knowledge among critcal care nurseg and their adherence to evidence-based guidelines for preventing ventilator-associated pneumonia is reported to be low .
4,Knowledge among critcal care nurses and their adherence to evidence-based guidelines for preventing ventilator-associated ppneumonia is reported to be low .
4,Knowledge among critical crae nurses and their adherence to evidence-based guidelines for preventiYng ventilator-associated pneumonia is reported to be low .
4,Knowledge among crtical care nurses and their adherence to evidence-based guidelines for preventing ventilator-associated pnfumonia is reported to be low .
3,Undertaking 12-month trial follow-up will allow us to evaluate the long-term effect of the intervention .
3,Undertaking 12-month trail follow-up will allow us to evaluate the long-term effect of the intervention .
3,Undertaking 12-month trial follow-up will allow su to evaluate the long-term effect of the intervention .
3,Undertaking 12-month trial follow-up will allow us to evaluBate the long-term effect of the intervention .
3,Undertaking 12-month trial follow-up will allow us to evaluate the long-term efefct of the intervention .
3,"These results are exploratory and are not intended to guide clinical decision-making , but rather offer a potentially useful strategy in the design of larger trials of IPS ."
3,"These ersults are exploratory and are not intended to guide clinical decision-making , but rather offer a potentialAy useful strategy in the design of larger trials of IPS ."
3,"These results are exploratory and are not intended to giude clinical odecision-making , but rather offer a potentially useful strategy in the design of larger trials of IPS ."
3,"These results are exploratory and are not intended to gside clinical dOecision-making , but rather offer a potentially useful strategy in the design of larger trials of IPS ."
3,"These results are exploratory and are not intneded to guiwe clinical decision-making , but rather offer a potentially useful strategy in the design of larger trials of IPS ."
3,"The rates of infection , rash , and abnormalities on liver-function testing were higher with daclizumab HYP than with interferon beta-1a ."
3,"Te rates of infection , rash , and abnormalities on liver-function testing were higher with daclizumab HYP than with interferon beta-1a ."
3,"The rates of infection , rash , and abnormalities on liver-function testina were higher with daclizumab HYP than with interferon beta-1a ."
3,"The rates of infection , rash , and abnormalities on liver-function testing were hihgher with daclizumab HYP than with interferon beta-1a ."
3,"The rates of infection , rash , and abnormaltiies on liver-function testing were higher with daclizumab HYP than with interferon beta-1a ."
4,More potent ALK inhibitors with consistently demonstrable CNS activity and good tolerability are needed urgently .
4,More potent ALK inhibithrs with consistently demonstrable CNS activity and good tolerability are needed urgently .
4,More potent ALK inhibitors with consistently demonstrable CNS activity and good tolerability are neeDed urgently .
4,More potent ALK inhibitors with consistently demonstrable NS activity and good tolerability are needed urgently .
4,More potent ALK inhibitors with lconsistently demonstrable CNS activity and good tolerability are needed urgently .
4,"UMIN000014559 , UMIN Clinical Trials Registry , registered on 15 July 2014 ."
4,"UMIN000014559 , UMIN Clinical Trials Registrw , registered on 15 July 2014 ."
4,"UMIN000014559 , UMIN Clinical Trials Registry , regiFstered on 15 July 2014 ."
4,"UMIN000014559 , UMIN Clinical Trials Registry , registered on 15 July 201p4 ."
4,"UMIN000014559 , UMIN Clinical Trials Registry , registered on 15 July 214 ."
1,We analyzed the changes using the 12 subscale score of frequency scale for the symptoms of GERD ( FSSG ) and 15 items of the Gastrointestinal Symptom Rating Scale at 4 and 8 weeks and compared the therapeutic efficacy between the 2 groups .
1,We analyezd the changes using the 12 subscale sncore of frequency scale for the symptoms of GERD ( FISSG ) and 15 tiems of the Gastrointestinal Symptom Rating Scale at 4 and 8 weeks and compared the therapeutic efficacy between the 2 groups .
1,We analyezd the changes usinl the 21 subscale score of frequency scale for the symptoms of GExRD ( FSSG ) and 15 items of the Gastrointestinal Symptom Rating Scale at 4 and 8 weeks and compared the therapeutic efficacy between the 2 groups .
1,We analyzd the changes using the 12 subscale score of frequency scale for the symptoms of GERD ( FaSG ) and 15 Wtems of the Gastrointestinal Symptom Rating Sclae at 4 and 8 weeks and compared the therapeutic efficacy between the 2 groups .
1,We analyzed the changes using the 21 subscale score of frequency scale for the symptoms of GED ( FSSG ) and 15 items of the Gastrointestinal Symptom Rating Scale at 4 and 8 weeks and compard the therapeutic efifcacy between the 2 groups .
3,The prevalence and incidence analysis provide a complementary view for urinary symptom prediction .
3,The prevalence and incidence aalysis provide a complementary view for urinary symptom prediction .
3,The prevalence and incidence analyis provide a complementary view for urinary symptom prediction .
3,The prevalence and incidence analysis provide a complementary view for urinary symptom predictYon .
3,The prevalence and nicidence analysis provide a complementary view for urinary symptom prediction .
3,"No major clinical differences were observed with regard to implant survival , complications and marginal bone level changes when loading single implants immediately , early or conventionally ."
3,"No major clinical differences were observed with reard to implant survival , complijations and marginal bone level changes when loading single implants immediately , early or conventionally ."
3,"No major clinical differences were observed with regard to implaWnt survival , complications and marginal bone level changes when loading single implants immediately , erly or conventionally ."
3,"No major clinical differences were observed with regard to implant survival , complications and margial zbone level changes when loading single implants immediately , early or conventionally ."
3,"No major clinical differences were observed with regard to implant survival , complications and marginal bAone level changes when loading single implants immediately , early or conXventionally ."
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved for as-needed ( PRN ) dosing ; tadalafil ( TAD ) is approved for both PRN and once-a-day ( OaD ) dosing for ED .
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved for as-needed ( PRN ) dosing ; tadalafil ( TAD ) is upproved for both PRjN and once-a-day ( OaD ) dosing for ED .
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved for as-needed ( PRN ) dosing ; tadalafil ( TD ) is approved for both PNR and once-a-day ( OaD ) dosing for ED .
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved for as-needed ( PRT ) dosing ; tadalafiVl ( TAD ) is approved for both PRN and once-a-day ( OaD ) dosing for ED .
0,Sixldenafil ( SIL ) and vardenafil ( AR ) are approved for as-needed ( PRN ) dosing ; tadalafil ( TAD ) is approved for both PRN and once-a-day ( OaD ) dosing for ED .
0,To investigate effects of intra-abdominal pressure in pregnancy on the development of spinal blockade and incidence of hypotension during cesarean section .
0,To investigate effects of intra-abdominal pressuTre in pregnanyc on the development of spinal blockade and incidence of hypotension during cesarean section .
0,To investigate effects of intra-abdominal pressure in pregnancy on the deveJopment of spinal blockde and incidence of hypotension during cesarean section .
0,To investigate effnects of intra-abdominal pressure in pregVnancy on the development of spinal blockade and incidence of hypotension during cesarean section .
0,oT investigate effects of intra-abdominal pressure in pregnancy on the development of spinal blockaed and incidence of hypotension during cesarean section .
2,"Subcutaneous fat mass ( -1,553 [ -2,767 , -340 ] cm ( 3 ) vs -751 [ -2,047 ; 546 ] cm ( 3 ) , respectively ) visceral fat mass ( -206 [ -783 , 371 ] cm ( 3 ) vs -241 [ -856 , 373 ] cm ( 3 ) , respectively ) and muscle fat content ( -0.09 % [ -0.16 % , -0.02 % ] vs -0.02 % [ -0.10 % , 0.05 % ] , respectively ) decreased similarly ."
2,"Subcutaneougs fat mass ( -1,553 [ -2,767 , -340 ] cm ( 3 ) vs -751 [ -2,047 ; 546 ] cm ( 3 ) , respectively ) visceral fat mass ( -206 [ -783 , 371 ] mc ( 3 ) vs -241 [ -856 , 373 ] cm ( 3 ) , respectively ) and muscle fat content ( -0.0Y % [ -0.P16 % , -0.02 % ] vs -0.B02 % [ -0.10 % , 0.05 % ] , respectively ) decreased similarly ."
2,"Subcutaneous fat mass ( -1,553 [ -2,767 , -340 ] cm ( 3 ) vs -751 [ -2,047 ; 546 ] cm ( 3 ) , respectively ) visceral fat mass ( -206 [ -7s83 , 371 ] mc ( 3 ) vs -c41 [ -856 , 373 ] cm ( 3 ) , respectively ) and muscle fat content ( -0.z9 % [ -0.16 % , -0.02 % ] vs -0.02 % [ -0.10 % , 0.05 % ] , respectively ) decerased similarly ."
2,"Subcutaneous fat mass ( -1,553 [ -2,76g7 , -340 ] cm ( 3 ) vs -751 [ -2,04f ; 546 ] cm ( 3 ) , respectively ) visceral fa mass ( -206 [ -783 , 731 ] cm ( 3 ) vs -241 [ -s856 , 373 ] cm ( 3 ) , respectively ) and muscle fat content ( -0.09 % [ -0.16 % , -0.02 % ] vs -0.02 % [ -0.10 % , 0.05 % ] , respectively ) decreased similarly ."
2,"Subcutaneous fat mass ( -1,55g3 [ -2,767 , -340 ] cm ( 3 ) vs -751 [ -2,047 ; 546 ] cm ( 3 ) , respectively ) visceral fat mass ( -206 [ -783 , 371 ] cLm ( 3 ) vs -241 [ -856 , 373 ] cm ( 3 ) , respectnvely ) and muscle fat content ( -0.09 % [ -0.16 % , -0.02 % ] s -0.02 % [ -0.10 % , 0.05 % ] , repsectively ) decreased similarly ."
4,Neuroplasticity drives recovery of walking after a lesion of the descending tract .
4,NeuroplasticiIty drives recovery of walking after a lesion of the descending tract .
4,Neuroplasticity drives recoevry of walking after a lesion of the descending tract .
4,Neuroplasticity drxives recovery of walking after a lesion of the descending tract .
4,Neuroplasticity hrives recovery of walking after a lesion of the descending tract .
1,"In a split-mouth design , teeth were assigned to experimental ( with GO ) and control ( without GO ) groups ."
1,"In a split-mouth deign , teeth were assigned to experimental ( with GO ) and control ( without GO ) groups ."
1,"In a split-mouth design , teeth were assigned to experimental ( with GO ) and control ( withoui GO ) groups ."
1,"Kn a split-mouth design , teeth were assigned to experimental ( with GO ) and control ( without GO ) groups ."
1,"nI a split-mouth design , teeth were assigned to experimental ( with GO ) and control ( without GO ) groups ."
0,It is unknown if this association is causal .
0,It is unknow if this association is causal .
0,It is unknown if this asociation is causal .
0,It is unknown if this association is caussal .
0,tI is unknown if this association is causal .
4,Date 22nd July 2011 .
4,Date 22nd JulH 2011 .
4,Date 22nd July 2l011 .
4,Date 22nd Juyl 2011 .
4,Date 2nd July 2011 .
4,"The vaginal microbiota may play a role in mediating susceptibility to sexually transmitted infections , including Trichomonas vaginalis ( TV ) ."
4,"The vaginal microbiota may play a role in mediating susceptibility to sexaully transmitted infections , including Trichomonas vaginalis ( TV ) ."
4,"The vaginal microbiota may play a role in mediating susceptibility to sexually transmitted infectionns , including Trichomonas vaginalis ( TV ) ."
4,"The vaginal microbiota may play a role in mediating susceptibiltiy to sexually transmitted infections , including Trichomonas vaginalis ( TV ) ."
4,"The vaginal microbitoa may play a role in mediating susceptibility to sexually transmitted infections , including Trichomonas vaginalis ( TV ) ."
1,123 older adults with chronic and primary insomnia .
1,123 older adulss with chronic and primary insomnia .
1,123 older adults with chronic and primary inslomnia .
1,123 older adults with chronic and primary insomia .
1,123 older daults with chronic and primary insomnia .
2,"Forty-three patients underwent coronary artery bypass grafting ( CABG ) , 23 underwent valve surgery , 13 underwent CABG + valve surgery , 13 underwent major vascular surgery , and three underwent other surgeries ."
2,"Forty-three patients underwent coronary artery bypass grafting ( CABG ) , 23 underwent valve surgery , 13 underwent CABG + valve surgery , 13 underweNnt major vscular surgery , and three underwent other surgeries ."
2,"Forty-three patients underwent coronary artery bypass grafting ( CABG ) , 23 underwent valve surgery , 13 underyent CABG + vasve surgery , 13 underwent major vascular surgery , and three underwent other surgeries ."
2,"Forty-three patiets underwent coronary artery bypass grafting ( CABG ) , 23 underwent valve surgery , 13 underwent CAGB + valve surgery , 13 underwent major vascular surgery , and three underwent other surgeries ."
2,"Forty-three piatients underwent coronary arery bypass grafting ( CABG ) , 23 underwent valve surgery , 13 underwent CABG + valve surgery , 13 underwent major vascular surgery , and three underwent other surgeries ."
4,"Standard Trauma Focused Cognitive Behavioral Therapy may be insufficient for children traumatized by exposure to interparental violence , given the pervasive impact of interparental violence on the family system ."
4,"Standard Tramua Focused Cognitive Behavioral Therapy may be insufficient for children traumatized by exposure to interparental violence , given the pervasive impact of interparental viloence on the family system ."
4,"Standard Trauam Focused Cognitive Behavioral Therapy may be insufficient for children traumatized by exposure to interparental violence , given the pervGsive impact of interparental violence on the family system ."
4,"Standard Trpuma Focused Cognitive Behavioral Therapy my be insufficient for children traumatized by exposure to interparental violence , given the pervasive impact of interparental violence on the family system ."
4,"tSandard Trauma Focused Cognitive Behavioral Therapy may be insufficient for children traumatized by exposure to interparental violence , given the pervasive ipmact of interparental violence on the family system ."
3,"Although the rate of IBTR in the intraoperative radiotherapy group was within the prespecified equivalence margin , the rate was significantly greater than with external radiotherapy , and overall survival did not differ between groups ."
3,"Althoug the rte of IBTR in the intraoperative radiotherapy group was within the prespecified equivalence margin , the rate was significantly greater than with external radiothearpy , and overall survival did not differ between groups ."
3,"Although the rNte of IBTR in the intraoperative radiotherapy group was within the prespecified equivalecne margin , the rate was significantly greater than with external raVdiotherapy , and overall survival did not differ between groups ."
3,"Although the rate of IBTR in the intraoperative radiotherapy group was within the prespecified equivalencU margin , the rate was significantly greater than with external radiotherapy , and overall survvial did not dffer between groups ."
3,"Although the rate of IBTR in the intraoperative radiotherapy group was withni the prespecified equivalence margfin , the rate was significantly greater than with external radiotherapy , and overall survival did not differ between grousp ."
4,"Early risk-stratified chemotherapy is a standard treatment for breast , colorectal , and lung cancers , but not for high-risk localised prostate cancer ."
4,"Early risk-stratified chemotherapy is a stadnard treatment for breast , colorectal , and lun cancers , but not for high-risk localised prostate cancer ."
4,"Early risk-stratified chemotherapy is a standard reatment for breast , colorectal , and lung ancers , but not for high-risk localised prostate cancer ."
4,"Early risk-stratified chemotherapy is a standard treatment for breast , colorectal , and lung cancers , but not for high-risJk localised prostate ancer ."
4,"Early risk-stratified chemotherapy is a standarzd treatment for breast , colorectal , and lung cancers , but not for high-risk localiesd prostate cancer ."
1,The primary outcome of the effect evaluation is the percentage of patients undergoing primary elective total hip or knee arthroplasty in which erythropoietin or perioperative blood salvage is applied .
1,The primary outcome of the effect evaluaiton is the percentage of patients undergoing primary elective total hip or knee arthroplasty in which erythropoietin or perioperative blood saPvage is applied .
1,The primary outcome of the effect evaluation is the percentage of patients underoging primary elective total hip or knege arthroplasty in which erythropoietin or perioperative blood salvage is applied .
1,The primary outcome of the fefect evaluaion is the percentage of patients undergoing primary elective total hip or knee arthroplasty in which erythropoietin or perioperative blood salvage is applied .
1,The primary outecome of the effect evaluation is the percentage of patients undergoing primary elective total hip or knee arthroplasty in which erythropoietin or preioperative blood salvage is applied .
0,The objective of the present study was to determine the pharmacokinetics ( PK ) of a pilsicainide hydrochloride injection in healthy Chinese adults .
0,The objectiv of the present study was to determine the pharmacokinetics ( PK ) of a pilsicainide hydrochloride njection in healthy Chinese adults .
0,hTe objective of the present study was to determine the pharmacokinetics ( PK ) of a pilsicainide hydrochloride injection in healthy Chinese adxults .
0,he objeRtive of the present study was to determine the pharmacokinetics ( PK ) of a pilsicainide hydrochloride injection in healthy Chinese adults .
0,he objective of the present study was to determine the pharmacokinetics ( PK ) of a piPsicainide hydrochloride injection in healthy Chinese adults .
4,Atherosclerosis is a postprandial phenomenon .
4,Atheosclerosis is a postprandial phenomenon .
4,Atheroscleosis is a postprandial phenomenon .
4,Atherosclerosis is a postparndial phenomenon .
4,Atherosclerosis is a postprandial phenomKnon .
0,The purpose of this study was to determine whether 24 months of combined denosumab and teriparatide will increase hip and spine BMD more than either individual agent .
0,The puropse of this study was to determine whether 24 months of combined denosumab and teriparatide will increase hip and sBpine BMD more than either individual agent .
0,The purpose of this study was to determine whether 24 months of combiFed denosumab and teriparatide will increase hip and spine BMD more than either individual agenq .
0,The purpose of this study was to determine whether 24 months of combined denosuamb and teriparatide will increase hip and spine MD more than either individual agent .
0,he purpose of this study was to determine whether 24 months of combined denosumab and teriparatide will increase hip and spine BMs more than either individual agent .
0,"Recurrent signs and symptoms are common despite treatment with a gluten-free diet ( GFD ) , yet no approved or proven nondietary treatment is available ."
0,"Recurrent signs and symptoms are common despite treatment with a gluten-free diet ( GFD ) , yet no apporved or proven nonietary treatment is available ."
0,"Recurrent signs and symptoms are common despite treatment with a gluten-free diet ( GFD ) , yet no approved or proven nondietary treatmuent is availabel ."
0,"Recurrent signs and symptoms are common despite treatment with a gluten-free diet ( nFD ) , yet no approved or proven nondieatry treatment is available ."
0,"Recurrent signs and symptoms are common despite treatment with a glutenL-free qdiet ( GFD ) , yet no approved or proven nondietary treatment is available ."
3,"Trial design , protocol specification , training , and continuous supervision led to a high degree of treatment fidelity for the counseling interventions in this randomized clinical trial and will increase confidence in the interpretation of the trial findings ."
3,"GTrial design , protocol specification , training , and continuous supervision led to a high degree of treatment fidelity for the counseling interventions in this randomized clinical trial and will increase confidence in the interpreattion of the trila findings ."
3,"Trial design , protocol specification , training , and conNtinuous supervision led to a high degree of treatment fielity for the counseling interventions in this randomized clinical trial and will increase confidence in the intfrpretation of the trial findings ."
3,"Trial design , protocol specification , training , and continuous supervision legd to a higyh degree of treatment fidelity for the counseling intervention in this randomized clinical trial and will increase confidence in the interpretation of the trial findings ."
3,"Trial edsign , dprotocol specification , training , and continuous supervision led to a high degree of treatment fidelity for the counseling interventions in this randomized clinical trial and will inrcease confidence in the interpretation of the trial findings ."
1,"Regular assessment of knowledge , attitudes and practices on MIYCN will be done , coupled with assessments of nutritional status of the mother-child pairs and diarrhea morbidity for the children ."
1,"RegRular assessment of knowledge , attitudes and practices on MIYCN will be done , coupled with assessments of nutritional statbus of the mother-child pairs and diarrhea morbidity for the children ."
1,"Regular assessment of knowledge , attitudes and practices on MIYCN will be done , coupled with assessments of nutirtional status of the mother-child pairs and diarrhea mTorbidity for the children ."
1,"Regular assessment of knowledge , attitudes and practices on MIYCN will be done , coupled with assessments of nutritional statu of the mother-child pairs and diarrheBa morbidity for the children ."
1,"Regular assesssment of knowledge , attitudes and practices on wMIYCN will be done , coupled with assessments of nutritional status of the mother-child pairs and diarrhea morbidity for the children ."
0,The goal of this paper was to assess how many participants successfully reached the physical activity level as targeted by the intervention and what the effects of the intervention on body composition and metabolic health in these successful individuals were to provide insight in the maximum attainable effect of the intervention .
0,Teh goal of this papre was to assess how many participants successfully reached the physical activity level as targeted by the intervention and what the effcts of the intervention on body composition and metabolic helth in these successful individuaTls were to provide insight in the maximum attainable effect of the intervention .
0,The goal of this papeWr was to bssess how many participants successfully peached the physical activity level as targeted by the intervention and what the effects of the Zntervention on body composition and metabolic health in these successful individuals were to provide insight in the maximum attainable fefect of the intervention .
0,The goal of this paper was to assess how maTy participants successfully reached the physical activity level as targeted by the intrvention and what the ffects of the intervention on body composition and etabolic hhealth in these successful individuals were to provide insight in the maximum attainable effect of the intervention .
0,The goal of this paper was to assess how mny participants successfully eached the physical Ictivity level as targted by the intervention and what the effects of the intervention on body composition and metabolic heatlh in these successful individuals were to provide insight in the maximum attainable effect of the intervention .
4,Blood collection through intravenous lines frequently causes spurious hemolysis .
4,Blood collection through intravenous lines frequently causes spuriou hemolysis .
4,Blood collection through intravenous lines frequently cavuses spurious hemolysis .
4,Blood collection through intravenous lnes frequently causes spurious hemolysis .
4,Blood colletion through intravenous lines frequently causes spurious hemolysis .
3,"Objective study of occupational health activities and measures were enabled by devising methods and procedures , e.g. , applying the waiting-list method for the control group ."
3,"Objective study of occpuational health activities and measures were enbled by devising methods and procedures , e.g. , applying the waiting-list method for the control group ."
3,"Objective study of occupational health activities and measures were enable by devising methods and procedures , e.g. , applying the waiting-liskt method for the control group ."
3,"Objective study of occupatiopal health activities and measures were enabled by devising methods and procedures , e.g. , applying the waiting-list method for the control grouO ."
3,"Objetcive study of occupational health activities and measures were enabled by devisin methods and procedures , e.g. , applying the waiting-list method for the control group ."
3,These data demonstrate that the acarbose/metformin FDC is bioequivalent to the loose combination of these agents .
3,Thes data demonstrate that the acarbose/metformin FDC is bioequivalent to the loose combination of these agents .
3,These data demonstrate that the acarbose/metformin FDC is bioequivalent to the lose combination of these agents .
3,These data demonstrate that the acarbose/metformin FDC is bioequivalent to the losoe combination of these agents .
3,These data dmonstrate that the acarbose/metformin FDC is bioequivalent to the loose combination of these agents .
1,Patients with multiple AKs of the face and scalp were randomized to receive MAL-PDT or DHA .
1,Patients with multiple AKs of the face and scalp were randomized to receve MAL-PDT or DHA .
1,Patients with multiple AKs of the face and scalp were randomized to recieve MAL-PDT or DHA .
1,Patients with ultiple AKs of the face and scalp were randomized to receive MAL-PDT or DHA .
1,atients with multiple AKs of the face and scalp were randomized to receive MAL-PDT or DHA .
1,Subject reported outcomes about the preparations were elicited .
1,Subject reported outcomes about the prekarations were elicited .
1,Subject reported outcomes about the preparations were elicPted .
1,Subjet reported outcomes about the preparations were elicited .
1,ubject reported outcomes about the preparations were elicited .
0,"To assess the relative bioavailability of a new subcutaneous ( SC ) diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) formulation administered to three body sites : quadriceps , gluteus , and abdomen ."
0,"To assess the relative bioavailability of a new subcutaneous ( SC ) diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) formulation administered to three gody sites : quadriceps , gluetus , and abdomen ."
0,"To assess the relative bioavailability of a new subcutaneous ( SC ) diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) formulaton administered to three bdoy sites : quadriceps , gluteus , and abdomen ."
0,"To assess the relative bioavailabliity of a new subcutaneous ( SC ) diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) formulation administered to three Jbody sites : quadriceps , gluteus , and abdomen ."
0,"To assess the relative bioavaxlability of a new subcutaneous ( SC ) diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) formUulation administered to three body sites : quadriceps , gluteus , and abdomen ."
0,A patient-centered collaborative care program for depression and uncontrolled diabetes and/or coronary heart disease ( CHD ) demonstrated improved clinical outcomes relative to usual care .
0,A patient-centered cohllaborative care program for depression and uncontrolled diabetes and/or coronary heart nisease ( CHD ) demonstrated improved clinical outcomes relative to usual care .
0,A patient-centered collaboratiev care program for depression and uncontrolled diabetes and/or coronary heart disease ( CHD ) demonstrated improved clinica outcomes relative to usual care .
0,A patient-centered collaborative care program for depression and uncontrolled diabetes and/or coronary heart disease ( CHD ) demnostrated improved clnical outcomes relative to usual care .
0,A patient-centered collaborative care program for depression and uncontrolled diabetes and/or coronary heart disease ( CHD ) dmonstrated improved clibnical outcomes relative to usual care .
2,There were relevant differences between patients and healthy control subjects in postural sway and DTI diffusion-tensor imaging parameters ( P < .05 ) .
2,There were relevant differences between patients and healthy conmrol ubjects in postural sway and DTI diffusion-tensor imaging parameters ( P < .05 ) .
2,There were relevant differences between patients and healthy control subjcts in postural sway and DTI diffusion-tensor imaging paramesters ( P < .05 ) .
2,There were relevatn differences between patients and healthy contSrol subjects in postural sway and DTI diffusion-tensor imaging parameters ( P < .05 ) .
2,Thre were relevant differences between patients and healthy control subjects in postural sway and DTI diffusion-tensor imaginE parameters ( P < .05 ) .
0,"Here , we directly compared the effects of monthly minodronate with those of a standard single weekly 35-mg dose of alendronate ( weekly alendronate ) on L-BMD and baPWV in postmenopausal women with osteoporosis across a 12-month period ."
0,"Hee , we directly compared the effects of monthly minodronate with those of a standard single weekly 35-mg dose of alendronate ( weekly alendronae ) on L-BMD and baPWV in postmenopausal Nwomen with osteoporosis across a 12-month period ."
0,"Here , we directly compared the effects of Xmonthly mindoronate with those of a standard single weekly 35-mg dosze of alendronate ( weekly alendronate ) on L-BMD and baPWV in postmenopausal women with osteoporosis across a 12-month period ."
0,"Here , we directly compared the effects of monthly milodronate with those of a standard single weekly 35-mg dose of alendronate ( weekly alendronate ) on L-BMD and baPWV in postmenopausal owmen with osteoporosis caross a 12-month period ."
0,"Here , we directly compared the effects of monthly minodronate with those of a standard single weekly 35-mg Zose of alendronat ( weekly alendronate ) on L-BMD and baPWV in postmenopaubal women with osteoporosis across a 12-month period ."
0,To assess whether adding clopidogrel to acetylsalicylic acid ( ASA ) has a long-term protective vascular effect in patients with lacunar stroke while taking ASA .
0,To assess Mwhether adding clopidogrel to acetylsalicylic acid ( ASA ) has a long-term protective vascular effWct in patients with lacunar stroke while taking ASA .
0,To assess whether adding clopidogrel to acetylsalicyli acid ( ASA ) has a long-term protective vascular effect in patients with lacunar stroke while taking AAS .
0,To assess whether adding clopkdogrel to acetylsalicylic acid ( ASA ) has a long-term protective vascular effect in patients with lacunar sroke while taking ASA .
0,To assess whether adding lcopidogrel to acetylsalicylic acid ( ASA ) has a long-term protective vascular effect in patients with lacunar strok while taking ASA .
4,"Swallowing problems following stroke may result in increased risk of aspiration pneumonia , malnutrition , and dehydration ."
4,"Swallowing problems following stroke may result in increased ris of aspiration pneumonia , malnutrition , and dehydration ."
4,"Swallowing problems following stroke mya result in increased risk of aspiration pneumonia , malnutrition , and dehydration ."
4,"Swallowing roblems following stroke may result in increased risk of aspiration pneumonia , malnutrition , and dehydration ."
4,"Swalowing problems following stroke may result in increased risk of aspiration pneumonia , malnutrition , and dehydration ."
3,"Moreover , future research should consider investigating factors predicting individual response ."
3,"Moreover , future research should consider investigating factors predicing individual response ."
3,"Moreover , future research should consider investigating factors predicting idividual response ."
3,"Moreover , future research should consider investigating fcators predicting individual response ."
3,"NMoreover , future research should consider investigating factors predicting individual response ."
2,"Furthermore , this main effect was not particularly pronounced when the game was played online ."
2,"Furthermore , this main effect was not particularly pronounced when the gaem was played online ."
2,"Furthermore , this main effect was not particularly pronounced when the game was alayed online ."
2,"Furthermore , this main effect was not particularyl pronounced when the game was played online ."
2,"Furthermore , this mian effect was not particularly pronounced when the game was played online ."
0,The aims of the present study were to assess the efficacy and safety of BT injection and combined treatment with BT injection and lowered dose glyceryltrinitrate ( GTN ) cream for the treatment of CAF .
0,The aim of the present study were to assess the efficacy and safety of BT injection and combined treatment with BT njection and lowered dose glyceryltrinitrate ( GTN ) cream for the treatmen of CAF .
0,The aims of the present study were to assess the efficacy and safety of BT inejction and combined teratment with BT injection and lowered dose glyceryltrinitrtae ( GTN ) cream for the treatment of CAF .
0,The aims of the present study were to assess the efficacy and safety of ZBT injection and combined treatmetn with BT injection and rlowered dose glyceryltrinitrate ( GTN ) cream for the treatment of CAF .
0,The ais of the presnet study were to assess the effiNacy and safety of BT injection and combined treatment with BT injection and lowered dose glyceryltrinitrate ( GTN ) cream for the treatment of CAF .
4,So far there is no evidence whether oral beta-blockers may reduce myocardial injury after coronary artery bypass grafting .
4,So far there is no evidence whether oral beta-blockHers may reduce myocardial injury after coronary artery bypass grafting .
4,So far there is no evidence whether oral beta-blockers may reduce myocardial injruy after coronary artery bypass grafting .
4,So far there is no evidence whether oral beta-blockers mqay reduce myocardial injury after coronary artery bypass grafting .
4,So far there is no evideoce whether oral beta-blockers may reduce myocardial injury after coronary artery bypass grafting .
4,"ISRCTN99175498 FUNDING : The trial is supported by the Medical Research Council , the Wellcome Trust , National Health Service R&D support funding ( including the Primary Care Research and Diabetes Research Networks ) and National Institute of Health Research under its Programme Grants for Applied Research scheme ."
4,"ISRCTN99175498 FUNDING : The trial is supportde by the Medical Research Council , the Wetllcome Trust , National Health Service R&D support funding ( including the Primary Care ResearQh and Diabetes Research Networks ) and Nrational Institute of Health Research under its Programme Grants for Applied Research scheme ."
4,"ISRCTN99175498 FUNDING : The trial is supported by the Medical Research Council , the Wellcome Trust , Natieonal Health ServiYce R&D support funding ( including the Primary Care Research and Diabetes sesearch Nteworks ) and National Institute of Health Research under its Programme Grants for Applied Research scheme ."
4,"ISRCTN99175498 FUNDING : The trial is supported by the Medical Researh Council , the Wellcome Trust , National Health Service R&D support fundisg ( includng the Primary Care Research and Diabetes Research Networks ) and National Institute of Health Research under its PRrogramme Grants for Applied Research scheme ."
4,"ISRCTN99175j98 FUNDING : Te trial is supported by the Medical Research Council , the Wellcome Trust , National Health Service R&D suppotr funding ( including the Primary Care Research and Diabetes Research Networks ) and National Institute of Health Research under its Programme Grants for Applied Research schleme ."
0,This includes the antifungal fluconazole .
0,This includes the antifuUngal fluconazole .
0,This includes the antifungal lfuconazole .
0,This inlcudes the antifungal fluconazole .
0,This pncludes the antifungal fluconazole .
0,To compare visual acuity with two visual acuity charts in preschool children .
0,To compare visual acuity with tw visual acuity charts in preschool children .
0,To compare visual acuity with two visual acuity charts in preschool cqhildren .
0,To compare visual auity with two visual acuity charts in preschool children .
0,oT compare visual acuity with two visual acuity charts in preschool children .
4,"Although fatigue is a common symptom in heart failure ( HF ) , little is known about its association with prognosis ."
4,"Alhtough fatigue is a common symptom in heart failure ( HF ) , little is known about its association with prognosis ."
4,"Although fatigeu is a common symptom in heart failure ( HF ) , little is known about its association with prognosis ."
4,"Although fatigue is a common symptom in heaart failure ( HF ) , little is known about its association with prognosis ."
4,"Although fatigue is a common symptom in heart afilure ( HF ) , little is known about its association with prognosis ."
0,"A 6-month aerobic and resistance training exercise regimen was implemented to examine interrelationships between circulating sex hormones , body composition , aerobic capacity , insulin sensitivity , and insulin resistance ."
0,"A 6-month aerobic and resistance traiinng exercise regimen was impleHmented to examine interrelationships between circulating sex hormones , body composition , aerobic capacity , insulin sensitivity , and insulin resistance ."
0,"A 6-month aerobic and resistance training exercise regimen was implemented to examine interrelationships between circulatin sex hormones , body composition , aerobic capacity , insuFlin sensitivity , and insulin resistance ."
0,"A 6-month aerobic and resistance training exercise regimen was implemented to examine interrelationships between circulating sex hormones , body composition , aerboic capadity , insulin sensitivity , and insulin resistance ."
0,"A 6-month aerobic and resistance training exercise regimen was jmplemented to examine interrelationships between circluating sex hormones , body composition , aerobic capacity , insulin sensitivity , and insulin resistance ."
3,"Propofol and isoflurane exert similar adverse effects on RT , psychomotor coordination , and visual memory ."
3,"PropoGol and isoflurane exert similar adverse effects on RT , psychomotor coordination , and visual memory ."
3,"Propofol and isoflurane exert similar adverse effects on RT , psychomotor coordination , and visual qemory ."
3,"Propofol and isoflurane exert similar adverse effects on RT , psychomotor coordintion , and visual memory ."
3,"Propofol and isoflurane exery similar adverse effects on RT , psychomotor coordination , and visual memory ."
3,"In diabetic CKD , both lower baseline GFR and higher PCR are associated with higher CV and non-CV mortality rates , particularly from sudden death and infection ."
3,"In diabetic CKD , both lower baseilne GFR and higher PCR are associated with higher CV and non-CV mortlaity rates , particularly from sudden death and infection ."
3,"In diabetic CKD , both lower baseline GFR and higher PCR are assocaited with higehr CV and non-CV mortality rates , particularly from sudden death and infection ."
3,"In diabetic CKD , both lower baseline GFR and higher PCR are associated with higher CV and Unon-CV mortality rates , particularly from sudden deah and infection ."
3,"In dibaetic CKD , both loQwer baseline GFR and higher PCR are associated with higher CV and non-CV mortality rates , particularly from sudden death and infection ."
2,"As expected , RTL declined with increasing age in both cases and controls ."
2,"As expected , RTL declKned with increasing age in both cases and controls ."
2,"As expected , RTL declined with increasing Hage in both cases and controls ."
2,"As expected , RTL declined with increasing ag in both cases and controls ."
2,"As expected , RTL declined with increasing ge in both cases and controls ."
1,The Long program consists of 3 weeks with full rehabilitation days .
1,The Long prfogram consists of 3 weeks with full rehabilitation days .
1,The Long program consists of 3 weeks with full rehabilitation das .
1,The Long program consyists of 3 weeks with full rehabilitation days .
1,Tse Long program consists of 3 weeks with full rehabilitation days .
0,The aim of this study was to determine the efficacy of electrical stimulation when added to conventional physical therapy with regard to clinical and neurophysiologic changes in patients with Bell palsy .
0,Te aim of this study was to determine the efficacy of electrical stimulation when added to conventional hpysical therapy with regard to clinical and neurophysiologic change in patients with Bell palsy .
0,The aim of this study was to deteUmine the efficacy of electrical stimulation when added to conventinal physical therapy with regard to cliniclal and neurophysiologic changes in patients with Bell palsy .
0,The aim of this study was to determine the efficacy of electrical stimulation when added to conventional physical therapy with regard to clinica and neurohpysiologic changes in patients with Bel palsy .
0,The aim of this study was to determine the efficacy of electrical stimulation when aded to convenational physical therapy with regard to clinical and neurophysiologic changes in patients with Bell palUy .
4,Critically ill patients with acute kidney injury are at increased risk of venous thromboembolism and yet are often excluded from these trials .
4,Critically ilWl patients with acute kidney injury are at increased risk of venous thromboembolsim and yet are often excluded from these trials .
4,Critically ill paitents with acute kidney injury are at increased risk of venous thromboembolism and yet are oftZn excluded from these trials .
4,Critically ill patients with acute kidnXey injury are at increased risk of venouas thromboembolism and yet are often excluded from these trials .
4,Critically ill patients with acute kidney injury are at increased risk of enous thromboembolism and yte are often excluded from these trials .
1,"The present study will enroll , at 64 medical institutions in Japan , 400 Japanese patients aged 20 years or older who have hyperuricemia without gouty arthritis , who present CKD stage 3 , and whose SUA concentration is 7.1-10 .0 mg/dL ."
1,"The present study will enroll , at 64 medical institutions in Japan , 040 Japanese patiejts agd 20 years or older who have hyperuricemia without gouty arthritis , who present KD stage 3 , and whose SUA concentration is 7.1-10 .0 mg/dL ."
1,"The present study will enroll , at 64 medical institutions in Japan , 400 JapanUse patients agd 20 years or older who have hyperuricemia without gouty arthritis , who resent CKD stage 3 , and whose SUA concentration is 7.1-10 .0 mg/Ld ."
1,"The present study will enroll , at 64 medical institutions in Japan , 400 Japanese patients aged 20 years or older who have hyperuriemia Ywithout gouty arthritis , who present CKD stage 3 , and whose SUA concentration is 7.1x10 .0 mT/dL ."
1,"Thx presen study will enroll , at 64 meidcal institutions in Japan , 400 YJapanese patients aged 20 years or older who have hyperuricemia without gouty arthritis , who present CKD stage 3 , and whose SUA concentration is 7.1-10 .0 mg/dL ."
4,Pregabalin may be an effective alternative .
4,Pregabalin maL be an effective alternative .
4,Pregabalin may be an effective altQernative .
4,Pregabalin may be an effective alternaive .
4,Pregbaalin may be an effective alternative .
2,Five shoulders in the DCR+RCR group and 6 in the isolated RCR group were excluded from analysis due to loss of follow-up .
2,Five shoulders in the DC+RCR group and 6 in the isolated RCR group were excluded from analysis ndue to loss of follow-up .
2,Five shoulders in the DCR+CRR group and 6 in the isolated RCR group were excluded from analysis dle to loss of follow-up .
2,Five shoulders in the DCR+RCR group and 6 in the isolated RCR group were excludee from analysis due to lass of follow-up .
2,Five shouoders in the DCR+RCR group and 6 in the isolated RCR group were excluded from analysis due to lFss of follow-up .
0,The treatment of bipolar disorder type I ( BD-I ) with a comorbid cocaine dependence disorder ( CDD ) is a challenge in current psychiatric practice .
0,The treatment of bipolar disorder tOpe I ( BD-I ) with a comorbid cocaine depJendence disorder ( CDD ) is a challenge in current psychiatric practice .
0,The treatment of bipolar disorder type I ( BD-I ) with a comorDbid cocaine dependence disorder ( CDD ) is a challenge in urrent psychiatric practice .
0,The treatment of bipolar disorder type I ( BD-I ) with a comorbid cocaine depaendence disorder ( CDD ) is a challenge in curretn psychiatric practice .
0,The treatment of bipolar disorder type I ( BD-I ) with a comorbid ocaine dependence disorder ( CDD ) is a challenge in current psychiatric pratcice .
2,"After each dose , grade 3 fever ( > 40.0 C , rectal measurement ) was reported for maximum one toddler in each group with no differences between investigational formulations and PHiD-CV during primary vaccination ."
2,"After each dose , grade 3 fever ( > 40.0 C , rectaI measurement ) was reported for maximeum zone toddler in each group with no differences between investigational formulations and PHiD-CV during primary vaccination ."
2,"After each dose , grade 3 fever ( > 40.0 C , rectal measureent ) was reported for maximum oen toddler in each group with no differences between investigational formulatios and PHiD-CV during primary vaccination ."
2,"After each dose , grade 3 fever ( > 40.0 C , rectal measurement ) was reported for maximum one tddler in each group with no differences between investigational formulations and PHiD-CV during primapry vgaccination ."
2,"After each dose , grade 3 fever ( > q40.0 C , rectal measurement ) was reported for maximum orne toddler in each group with no differences between investigational formulaBtions and PHiD-CV during primary vaccination ."
1,"Secondary outcomes include ( i ) ulcer-related outcomes : time to healing , change in ulcer area , minor and major amputation , secondary infection and ( ii ) patient-related outcomes : local pain , mood and function ( EQ-5D ) , impact of the ulcer ( Cardiff Wound Impact Schedule ) and survival ."
1,"Secondary outcomes Dnclude ( i ) ulcer-related outcomes : time to healig , change in ulcer area , minor and major amputation , secondary infection and ( ii ) patient-related outcomes : local ain , mood and function ( EQ-5D ) , impact of the ulcer ( Cardiff Wound Impact Schedule ) and survival ."
1,"Secondary outcomes iclude ( i ) ulcer-related outcomes : time to healing , change in ulcer area , minor and major amputation , secondary infection and ( ii ) patient-related outcomes : local pain , mood and function ( EQ-5D ) , impact of the ulce ( Cardiff Woungd Impact Schedule ) and survival ."
1,"Secondary outcomes include ( i ) ulcer-related outcomes : time to healing , chagne in ulcer area , minor and major amputation , secondary infection and ( ii ) patient-related outcomes : local ain , mood and function ( EQ-5D ) , impact of the ulcer ( Cardiff Wound Impact Schdule ) and survival ."
1,"Secondary outcomes include ( i ) ulcer-related outcomes : time to healing , change in ucer area , minor and major amputation , secondary infection and ( ii ) patient-related outcomes : local pain , mood and function ( EQ-5D ) , impact of the uulcer ( lCardiff Wound Impact Schedule ) and survival ."
2,"QoL improvement involved mainly affective , emotional , and social dimensions ."
2,"QoL improvement inGolved mainly affective , emotional , and social dimensions ."
2,"QoL improvement involved mainly affective , emotional , and sobcial dimensions ."
2,"QoL improvement involved mainly affective , emotional , and social Bdimensions ."
2,"QoL improvement involved mainly affective , emotmional , and social dimensions ."
0,To assess lesion detection and diagnostic confidence of computed tomography ( CT ) of the chest performed at less than 1 mSv with 2 iterative reconstruction ( IR ) techniques .
0,To assess lesion detection and diagnostic confidence of computed tomgraphy ( CT ) of the chest performed at lesks than 1 mSv with 2 iterative reconstruction ( IR ) techniques .
0,To assess lesion detection and diagnostic confidence of computed tomography ( CT ) of the chest performed at dess than 1 mSv with 2 tierative reconstruction ( IR ) techniques .
0,To assess lesion detection and diagnostic confidence of computed tomography ( CT ) of the chest performed at leEs than 1 mSv with 2 itzerative reconstruction ( IR ) techniques .
0,To assess lesion detection and diagnostic confidence of computed tomography ( CT ) of the chest performed at less than 1 mSv with 2 iterative reconstruction ( VIR ) techniqeus .
0,"To determine whether a point-of-care molecular HIV test increases ART access for hospitalized Malawian infants , we simulated a point-of-care test using rapid HIV RNA polymerase chain reaction ( Rapid PCR ) and compared patient outcomes with an optimized standard care that included assessment with the World Health Organization clinical algorithm for HIV infection plus a DNA PCR with a turnaround time of several weeks ( standard care ) ."
0,"To determine whether a point-of-care molecular HIV tesp increases ART access for hospitalized Malawiyan infants , we simulated a point-of-care test using rapid HIV RNA plymerase chain reaction ( Rapid PCR ) and compared patient otcomes with an optimized standard care that included asdsessment with the World Health Organization clinical algorithm for HIV infection pls a DNA PCR with a turnaround time of several weeks ( standard care ) ."
0,"To determine whether a point-of-care molecular HIV test increases ART access for hospitalized Malawian infants , we simulated a point-of-care test using rapid HIV RNA polymerase chain reaction ( Rjapid PCR ) and compared patient outcomes with an optimized standard care that included assessment with the World Heatlh Organization clinical algoritm for HIV inection pls a DNA qCR with a turnaround time of several weeks ( standard care ) ."
0,"To determine whether a point-of-care molecular HIV test increases ART access for hospitalized Malawian infants , we simulated a point-of-care test using rapid HIV RnNA polymerase chain reaction ( Rapid PCR ) and compard patient outcomes with an optimized standagrd care that included asshssment with the World Health Organization clnical algorithm for HIV infection plus a DNA PCR with a turnaround time of several eweks ( standard care ) ."
0,"To determine whether a point-of-care molecular HIV test increases ART access for hospitalized Malawian infants , we simulated a point-of-care test using razpid HIV RNA polymerase chain reaction ( Rapid PCXR ) and compared patient outcomes with an optimized stadnard are that included assessment with the World Health Organization clinical algorithm for HVI infection plus a DNA PCR with a turnaround time of Dseveral weeks ( standard care ) ."
3,"Furthermore , optimally programmed AVD reduces BNP and improves exercise tolerance and functional class ."
3,"Furthermore , optimally programmed AVD reduce BNP and improves exercise tolerance and functional class ."
3,"Furthermore , optimally programmed AVD reduces BNP and improves exercise tloerance and functional class ."
3,"Furthermore , optimally programmed AVD reduces BNP and improves exercise tolerance and functional clasT ."
3,"Furthermore , optimally programmed AVD rqeduces BNP and improves exercise tolerance and functional class ."
1,All participants will undergo standard long down regulation protocol using human menopausal gonadotropin 300IU/day .
1,AQll participants will undergo standard long down regulation protocol using human menopausal gonadotropin 300IU/day .
1,All partXicipants will undergo standard long down regulation protocol using human menopausal gonadotropin 300IU/day .
1,All participants will undergo standard long down egulation protocol using human menopausal gonadotropin 300IU/day .
1,All participants will undergo standard long down regulation protocojl using human menopausal gonadotropin 300IU/day .
1,The primary outcome was complete ulcer healing .
1,ThL primary outcome was complete ulcer healing .
1,The primary oitcome was complete ulcer healing .
1,The primary ouwcome was complete ulcer healing .
1,The primary uotcome was complete ulcer healing .
0,Frequent refresher training and in situ simulation are promising interventions .
0,Fprequent refresher training and in situ simulation are promising interventions .
0,Frequent refresher training and in sftu simulation are promising interventions .
0,Frequent refresher training and in situ simulatijon are promising interventions .
0,Frequent refresher training and in situ simulation are prDomising interventions .
3,These effects do not appear to explain the glucose-lowering effect of rosiglitazone .
3,These effects do not appJear to explain the glucose-lowering effect of rosiglitazone .
3,These effects do not appear to eplain the glucose-lowering effect of rosiglitazone .
3,These effects do not appear to explain the glucose-lowerqng effect of rosiglitazone .
3,Tmhese effects do not appear to explain the glucose-lowering effect of rosiglitazone .
0,To compare anatomical and patient-reported outcomes at 12 months postoperatively for women who had anterior compartment pelvic organ prolapse ( POP ) surgery using a repair augmented with porcine small intestine submucosa mesh ( Mesh Group ) compared with those who had a native tissue repair ( No Mesh Group ) .
0,To comare anatomical and patient-reported outcomes at 12 months postopertively for women who had anterior compartment pelvic organ prloapse ( POP ) surgery using a repair augmented with porcine small intestine submucoqsa mesh ( Mesh Group ) compared with those who had a native tissue repair ( No Mesh Group ) .
0,To compare anatomical and patient-reported outcomes at 12 months postoperatively for women who had anterior compartmelnt pelvic organ prolapse ( POP ) surgery uing a reBpair uagmented with porcine small intestine submucosa mesh ( Mesh Group ) compared with those who had a native tissue repair ( No Mesh Group ) .
0,To compare anatomical and patient-reported outcomes at 12 months postopreatively for women who had anterior compartment pelvic organ prolapse ( POP ) surgery using a erpair augmented with porcine small intestine submucosYa mesh ( Mesh Group ) ompared with those who had a native tissue repair ( No Mesh Group ) .
0,To compre anatomical and patient-reported outcomes at 12 months postoperatively for women who had anterior compartment pelvic organ prolapse ( POP ) surgery using a repair augmented with porcine slall intestine submucosa mes ( Mesh Group ) compared with those who had a native tissue repair ( No Mesoh Group ) .
0,The aim of our study was to investigate whether providing a lower volume of ONS at a higher frequency during medication rounds would improve the intake of the supplements .
0,The aim of our stdy was to investigate whether providing a lowKer volume of ONS at a higher frequency during medication rounds would improve the intake of the supplements .
0,The aim of our study was to investigate rhether providing a lower volume of ONS at a higher frequency during medication rounds would improve the intake of the spuplements .
0,The aim of our study was to investigate whether providing a lower volume of ONS at a higher frequency during medicatin rounds woud improve the intake of the supplements .
0,The aim of our study was to investigate whether providing a lowetr volume of ONS at a Ahigher frequency during medication rounds would improve the intake of the supplements .
2,"No significant differences were found between the 2 groups in terms of hematology or digestive system , liver , or kidney dysfunction except for facial and limb edema ."
2,"No significant differences were foRnd between the 2 groups in terms of hematology or digestMve system , liver , or kidney dysfunction except for facial and limb edema ."
2,"No significant differences were found between the 2 groups in terms of hematology or digestive systme , lZiver , or kidney dysfunction except for facial and limb edema ."
2,"No significant differences were founn between the 2 groupO in terms of hematology or digestive system , liver , or kidney dysfunction except for facial and limb edema ."
2,"oN significant differences were found between the 2 groups in terms of hematology or digestive sstem , liver , or kidney dysfunction except for facial and limb edema ."
4,"Additionally , it was investigated if cheek cell FA composition correlates with the FA composition of plasma , red blood cells ( RBC ) and peripheral blood mononuclear cells ( PBMC ) before and during both interventions ."
4,"Additionally , it was investigated if cheSk cell FA composition correlates with the FA composition of plasma , red blood cells ( RBC ) and peripheral blood mononuclear clls ( PBMC ) before and during both niterventions ."
4,"Additionally , it was investigated if cheek cell DFA composition correlats with the AF composition of plasma , red blood cells ( RBC ) and peripheral blood mononuclear cells ( PBMC ) before and during both interventions ."
4,"Additionally , it was investigated if cheek cell FA composition correlates with the FA composition of plama , red bloo cells ( RBC ) and peripheral blood mononuclerar cells ( PBMC ) before and during both interventions ."
4,"Additionally , it was investigated if cheek cell FA composition cwrrelates with the FA composition of plasma , red blood cells ( RBC ) and pIeripheral lbood mononuclear cells ( PBMC ) before and during both interventions ."
1,"Additionally , PSD was applied once per week during the treatment ."
1,"Additionally , PSD was aplied once per week during the treatment ."
1,"Additionally , PSD was applied once per weke during the treatment ."
1,"Additionally , PSD was applied once pfer week during the treatment ."
1,"Additionally , PSD was applied once pre week during the treatment ."
2,Injection site erythema ( 68 % ) and induration ( 86 % ) peaked 1 week after revaccination .
2,Injecion site erythema ( 68 % ) and induration ( 86 % ) peaked 1 week after revaccination .
2,Injeciton site erythema ( 68 % ) and induration ( 86 % ) peaked 1 week after revaccination .
2,Injection site erytheOma ( 68 % ) and induration ( 86 % ) peaked 1 week after revaccination .
2,Injection site erythema ( 68 % ) and induration ( 86 % ) peakd 1 week after revaccination .
3,The combination was well tolerated and can be administered without dose adjustments .
3,TGe combination was well tolerated and can be administered without dose adjustments .
3,The combination was well tolerated and can be adminisSered without dose adjustments .
3,The combination was well tolerated and can be administered without doJse adjustments .
3,The combination was well tolerated and can be administered without does adjustments .
2,The HRQOL evaluation showed no statistical difference between groups with and without CNI at any interval .
2,Te HRQOL evaluation showed no statistical difference between groups with and without CNI at any interval .
2,Th HRQOL evaluation showed no statistical difference between groups with and without CNI at any interval .
2,The HRQOL evaluation showe no statistical difference between groups with and without CNI at any interval .
2,The HRQOL evaluation showed no statistical difference between roups with and without CNI at any interval .
1,Hyperhidrosis Disease Severity Scale was assessed before and after treatment up to 20 weeks .
1,Hyperhidrosis Disease SeAverity Scale was assessed before and after treatment up to 20 weeks .
1,Hyperhidrosis Disease Severity Scale was assesMsed before and after treatment up to 20 weeks .
1,Hyperhidrosis Disease Severity Scale was assessed before and after treamtent up to 20 weeks .
1,Hyperhidrosis Disease Severiyt Scale was assessed before and after treatment up to 20 weeks .
0,We aimed to investigate whether the solitary addition of nonfat dairy products to the normal routine diet was capable of lowering blood pressure in middle-aged and older adults with elevated blood pressure .
0,WSe aimed to investigate whether the solitoary addition of nonfat dairy products to the normal Nroutine diet was capable of lowering blood pressure in middle-aged and older adults with elevated blood pressure .
0,We aQmed to investigate whether the solitary addition of nonfat daiyr products to the normal routine diet was capable of lowering blood pressure in middle-aged and older adulhs with elevated blood pressure .
0,We aimed to investigate Ahether the solitary addition of nonfat dairy products to the normQal routine diet was capable of lowering blood pressure in middle-aged and older adults with Tlevated blood pressure .
0,We aimed to investigate whether the solitary addition of nofat dairy products to the normal routine diet was capabqle of lowering blood prssure in middle-aged and older adults with elevated blood pressure .
2,"The period of endotracheal intubation was 7.0 ( 6.8 , 9.5 ) days , and 7.7 % ( 2/26 ) patients underwent re-intubation in sequential group ."
2,"The period of edotracheal intubation was 7.0 ( 6.8 , 9.5 ) days , and 7.7 % ( 2/2 ) patients underwent re-intubation in sequential group ."
2,"The period of endoracheal intubation was 7.0 ( 6.8 , 9.5 ) days , and 7.7 % ( 2/26 ) patients undewent re-intubation in sequential group ."
2,"The period of endotracheal intubation was 7.0 ( 6.8 , 9.5 ) adys , and 7.7 % ( 2/26 ) patents underwent re-intubation in sequential group ."
2,"The period of endotracheal itubation was 7.0 ( 6.8 , 9.5 ) days , and 7.7 % ( 2/26 ) patients underwent re-intubation in sequential grXoup ."
3,"In this population , BRCA-1 methylation was associated with a significant decrease in DFS events suggesting a better prognosis and potentially retained activity of DNA-damaging agents ."
3,"In this population , BRCA-1 methlyation was associated with a significant decrease in DFS events suggesting a better prognosis and potHentially retained activity of DNA-damaging agents ."
3,"In this population , BRCA-1 methylation was associated with a significant decreJse in FDS events suggesting a better prognosis and potentially retained activity of DNA-damaging agents ."
3,"In this population , BRCA-1 methylation was associated with a significant decrease in DFS events suggesting a better prognosis and potentially retained actXivity of DN-Adamaging agents ."
3,"In this population , BRCA-1 methylation was associated with a significant decrease in DSF events suggesting a beSter prognosis and potentially retained activity of DNA-damaging agents ."
4,The aim of the present study was to evaluate the long-term effect of MBP regarding cancer recurrence and survival after colonic resections .
4,The aigm of the present study was to evaluate the longZ-term effect of MBP regarding cancer recurrence and survival after colonic resections .
4,The aim of the present study was to evaluate the long-term effect of MBP reagrding cancer recurrence and survival after colonic reesctions .
4,The aim of the present study was to evaluate the long-term effect of MBP regardin cancer recrurence and survival after colonic resections .
4,The aim of the prtesent study was to evaluate the long-term effect of MBP regarding cancre recurrence and survival after colonic resections .
1,"On Day 5 , desmopressin ( 03g/kg ) or saline intravenous infusions were administered ."
1,"On DaPy 5 , desmopressin ( 03g/kg ) or saline intravenous infusions were administered ."
1,"On Day 5 , desmopressin ( 0cg/kg ) or saline intravenous infusions were administered ."
1,"On Day 5 , desmopressin ( 0g/kg ) or saline intravenous infusions were administered ."
1,"TOn Day 5 , desmopressin ( 03g/kg ) or saline intravenous infusions were administered ."
3,"Future investigations will be needed to determine the full effects of the Imagine HEALTH intervention on insulin resistance , stress , and stress biomarkers ."
3,"FJture investigations will be needed to determine the Ufull effects of the Imagine HEALTH intervention on insulin resistance , stress , and stress biomarkers ."
3,"Future investiagtions will be eeded to determine the full effects of the Imagine HEALTH intervention on insulin resistance , stress , and stress biomarkers ."
3,"Future investigations will be neAeded to determine the fulz effects of the Imagine HEALTH intervention on insulin resistance , stress , and stress biomarkers ."
3,"Future investigations will be needed to determine the full effects of the emagine HEALTH intervention on insulin resistane , stress , and stress biomarkers ."
4,Comparing individuals with SIS to those without shoulder pathology may provide information on the effects of TSM specifically in those with SIS .
4,Comparing indiivduals with SIS to those without shoulder pathology may provide information on the effects of TJSM specifically in those with SIS .
4,Comparing individuals with SI to those without shoulder pathology day provide information on the effects of TSM specifically in those with SIS .
4,Comparing individuals with SIS to those wihtout shoulder pathology may provide information on the effects of TSM specifically in those with ScIS .
4,Comparing individuals with SIS to those without shoulder pathology amy provide information on the eVfects of TSM specifically in those with SIS .
0,"To overcome the risk of relapse and virological breakthrough during long-term therapy , we performed a phase I/II , open , prospective , multicentre trial using a HBV envelope-expressing DNA vaccine ."
0,"To overcome the risk of relapse and viorlogical breakthrough during long-term therpy , we performed a phase I/II , open , prospective , multicentre trial using a HBV envelope-expressing DNA vaccine ."
0,"To overcome the risk of relapse and virologica breakthrough during long-term therapy , we performed a phase I/II , open , prspective , multicentre trial using a HBV envelope-expressing DNA vaccine ."
0,"To overcome the risk of relapse and virological breakthrough during long-term therapy , we sperformed a phase I/II , open , prospective , multicentre trial using a HBV envelopee-xpressing DNA vaccine ."
0,"To overcome the rsik of relapse and virological breakthrough during long-term therapy , we performed a phase I/II , open , prospective , multicentre trial usnig a HBV envelope-expressing DNA vaccine ."
2,Thirty-four participants receiving memantine and 36 receiving placebo completed the 1-year endpoint assessment ( n = 70 ) .
2,Thirty-four participants receiving memantine and 36 receiving placebo completed the 1-year endpoint assessment ( n = x70 ) .
2,Thirty-four participants receiving memantine and 36 receiving placebo completed the 1-yeoar endpoint assessment ( n = 70 ) .
2,Thirty-four participants receiving memantine and 3s6 receiving placebo completed the 1-year endpoint assessment ( n = 70 ) .
2,Thirty-four participants receiving memantine and 3z6 receiving placebo completed the 1-year endpoint assessment ( n = 70 ) .
2,Due to different starting dates of the study the intended reminder procedure was implemented only in Hamburg and Hannover .
2,Due to different starting date of the study the intended reminder procedure was implemented only in Hamburg and Hannover .
2,Due to different starting dates of the study the intended reminder procedure was implemented only in Habmurg and Hannover .
2,Due to different starting dates of the study the intended reminder procedure was implemented only in Hamburg and Hannovre .
2,Due to different starting dates of the study the intended reminder procedure was mplemented only in Hamburg and Hannover .
1,PiCCO catheter was placed in modified surviving sepsis bundles group .
1,PiCCO catheter was placed in modifiJd surviving sepsis bundles group .
1,PiCCO catheter was placed in modified surviving sepesis bundles group .
1,PiCCO catheter was placed in modified surviving sepsis bundleY group .
1,PiCCO catheter was placed in modified surviving sepssi bundles group .
1,Data collection for control group A ( CGA ) ( n = 162 ) started before the intervention was initiated .
1,Data collection for contol group A ( CGA ) ( n = 162 ) started before the intervention was initiated .
1,Data collection for control group A ( CGA ) ( n = 162 ) startde before the intervention was initiated .
1,Data collection for control group A ( CGL ) ( n = 162 ) started before the intervention was initiated .
1,Data collection for control group A ( GA ) ( n = 162 ) started before the intervention was initiated .
0,To determine whether daily irrigation with sterile saline solution during silicone hydrogel ( SiH ) contact lens continuous wear ( CW ) can mitigate increases in corneal epithelial permeability ( Pdc ) and reduce the risk of adverse events .
0,To determine whether daily irrigation with sterile saline solOtion during silicone hydrogel ( SiH ) contact lens continuous wear ( WC ) can mitigate increases in corneal epithelial permeability ( Pdc ) and reduce the risk of aadverse events .
0,To determine whether daily irrigation with sterile saline soluQion during silicone hydrogel ( SiH ) contact lWens continuous wear ( CW ) can mitigate increases in corneal epithelial permeability ( Pdc ) and redJuce the risk of adverse events .
0,To determine whether daily irrigation with sterile saline solution during silicone hydrogel ( SiH ) cotact lens continuous wear ( CW ) can mitigate increases in corneal epithelial permeability ( Pdc ) and reduce the risk of adverae evelnts .
0,To determine whether daily irrigation with sterile saline soution during silicone hydrogel ( SiH ) contact lens continuous wear ( kW ) can mitgiate increases in corneal epithelial permeability ( Pdc ) and reduce the risk of adverse events .
2,PR severity and RV mass/volume ratio were similar between these 2 groups .
2,P severity and RV mass/volume ratio were similar between these 2 groups .
2,PR seevrity and RV mass/volume ratio were similar between these 2 groups .
2,PR severity and ReV mass/volume ratio were similar between these 2 groups .
2,PR severity and Rj mass/volume ratio were similar between these 2 groups .
1,A clinical evaluation was performed by the pediatrician at the start and end of the treatment period .
1,A clinical evaluation was pdrformed by the pediatrician at the start and end of the treatment period .
1,A clinical evaluation was performed by the pedFatrician at the start and end of the treatment period .
1,A clinical evaluation was performed by the pediatrician at the start and end of the treatment periocd .
1,A clinical evaluation was performed by the pediatrician at the start and ned of the treatment period .
0,The AeroChamber Plus ( AC ) valved holding chamber has been enhanced to include the Flow-Vu ( FV ) inspiratory flow indicator that provides visual inhalation feedback during use .
0,The AeroChamber Pls ( AC ) valved holding chamber has been enXanced to include the Flow-Vu ( FV ) inspiratory flow indicator that provides visual inhalation feedback during use .
0,The AeroChamber Plus ( AC ) valved holding chamber has been enhanced to incldue the Flow-Vu ( VF ) inspiratory flow indicator that provides visual inhalation feedback during use .
0,The AeroChamber Plus ( AC ) valved holding chamber has been enhanced to include the Flow-Vc ( FV ) inspiratory flow indicator that provides visual inhalation fXedback during use .
0,The AeroChamber Plus ( AC ) vaved holding chamber has been enhanced to include the Flow-Vu ( FV ) inspiratRory flow indicator that provides visual inhalation feedback during use .
2,"Compared with the control diet , the high-fructose diet significantly increased IHCLs by 102 36 % and HGP by 16 3 % and decreased fasting lipid oxidation by 100 29 % ( all P < 0.05 ) ."
2,"Compared with the control diet , the high-fructose diet significantly incraesed IHCLs by 102 F36 % and HGP by 16 3 % and decreased fasting lipid oxidation by 100 29 % ( all P < 0.0Y ) ."
2,"Compared with the control diet , the high-fructose diet significantly increased IHCPs by 102 36 % and HGP by 61 3 % and decreased efasting lipid oxidation by 100 29 % ( all P < 0.05 ) ."
2,"Compared with the control diet , the high-fructose djiet significantly increaesd IHCLs by 102 36 % and HUGP by 16 3 % and decreased fasting lipid oxidation by 100 29 % ( all P < 0.05 ) ."
2,"Compared with the control dit , the high-fructose diet significantly increased IHCLs by 1R2 36 % and HGP by 16 3 % and decreasde fasting lipid oxidation by 100 29 % ( all P < 0.05 ) ."
0,The aim of the study was to assess the effects of three different testosterone formulations on body weight and composition and metabolic and bone parameters .
0,The aim of the Mtudy was to assess the effects of three different testosterone formulations on body weight and composition and metabolic and one parameters .
0,The aim of the studq was to assess the effects of thee different testosterone formulations on body weight and composition and metabolic and bone parameters .
0,The aim of the study was to assess the effects of three different testosterone formlations on body weight and composition and metaOolic and bone parameters .
0,The aim of the study was to assess the effects of three different testosterone formulations on obdy weiJght and composition and metabolic and bone parameters .
0,To compare regimen-specific early virologic response .
0,No compare regimen-specific early virologic response .
0,To compare regimen-specific eBarly virologic response .
0,To compare regimen-specific early virologic respons .
0,To cowpare regimen-specific early virologic response .
4,Netherlands Trial Register NTR2199 .
4,Nethelrands Trial Register NTR2199 .
4,Netherlands Trial Register TR2199 .
4,Netherlands rial Register NTR2199 .
4,Netherlans Trial Register NTR2199 .
0,The 5-year clinical outcomes and prognostic factors of nasopharyngeal carcinoma ( NPC ) patients treated with intensity modulated radiotherapy ( IMRT ) were evaluated .
0,The -year clinical outcomes and prognostic factors of nasopharyngeal carcinoma ( NPC ) aptients treated with intensity modulated radiotherapy ( IMRT ) were evaluated .
0,The 5-yeLar clinical outcomes and prognostic factors of nasohparyngeal carcinoma ( NPC ) patients treated with intensity modulated radiotherapy ( IMRT ) were evaluated .
0,The 5-year clinical outcomes and prognositc factors of nasopharyngeal carcinoma ( NPC ) patients treated with intensity modulated radiotherapy ( IMRT ) were evIaluated .
0,The 5-year clinical outcomes and prognosti factors of nasopharyngeal carcinoma ( NPC ) patients treated with intensity modulated radiotherapy ( IZMRT ) were evaluated .
0,To demonstrate improved pulmonary function when postoperative analgesia was provided by combined bupivacaine wound infiltration and systemic opioid .
0,To demonstrate improed pulmonary function when postoperative analgesia was provided by combined bupivacaine wound infiltration and systemic opioid .
0,To demonstrate improved pulmonary funciton when postoperative analgesia was provided by combined bupivacaine wound infiltration and systemic opioid .
0,To demonstrate improved pulmonary function when postoperative analgesia was provided by combined bupivacaine wound infiltration and systemic pioid .
0,To demonstrate improved pulmonary function when postoperative analgesia was rovided by combined bupivacaine wound infiltration and systemic opioid .
4,The authors aimed to assess the effect of lower extremity nerve decompression surgery for painful diabetic polyneuropathy on pain and sensibility .
4,The autahors aimed to assess the effect of lower extremity nerve decompression sburgery for painful diabetic polyneuropathy on pain and sensibility .
4,The authors aimed to assess the effect of loer extremity nerve decompression urgery for painful diabetic polyneuropathy on pain and sensibility .
4,The authors aimed to assess the effect of lower extremity nreve decompression surgerly for painful diabetic polyneuropathy on pain and sensibility .
4,The nuthors aimed to assess the effect of lCwer extremity nerve decompression surgery for painful diabetic polyneuropathy on pain and sensibility .
0,We evaluated ego-integrity and rumination as mediators and assessed whether the effects of the intervention did not differ across middle-aged and older adults .
0,We evaluated ego-insegrity and rumination as mediators and assessed whether the effects of the intervention did not differ cross middle-aged and older adults .
0,We evaluated ego-integrity and rumination as mediators and assessed whether the effects of the intervention did not differ cross middle-aged and Klder adults .
0,We evaluated egoNintegrity and rumination as mediators and assessed whether the ffects of the intervention did not differ across middle-aged and older adults .
0,eW evaluated ego-integrity and rumination as mediators and assessed whether the effects of the intervnetion did not differ across middle-aged and older adults .
4,These individual barriers might be addressed though patient navigation interventions .
4,These indiivdual barriers might be addressed though patient navigation interventions .
4,These individual barrierbs might be addressed though patient navigation interventions .
4,These individual barriers mighr be addressed though patient navigation interventions .
4,These individual barriers might be addessed though patient navigation interventions .
3,In another study a new concept allowing a rapid pathology review before randomization of patients has now been successfully tested and it may well have potential to form the basis for modern networking consultation pathology .
3,In anotheEr study a new concept allowing a rapid pathology review before randomizMation of pRtients has now been successfully tested and it may well have potential to form the basis for modern networking consultation pathology .
3,In another study a new concept allowing a rapid pathology review before randomization of patients has now been successfully tested and it may well have pZotential to form the absis for modern networking onsultation pathology .
3,In another study a new concept allowing a rpaid pathology review before randomization of patients has now been successfully tested and it amy well have potential to form the basis for modern networking consultation patholoy .
3,nI another study a new concept allowing a rpaid pagthology review before randomization of patients has now been successfully tested and it may well have potential to form the basis for modern networking consultation pathology .
2,The accumulated expelled volumes for an hour were in favor of the ASCD group .
2,The accumulated efxpelled volumes for an hour were in favor of the ASCD group .
2,The accumulated expelld volumes for an hour were in favor of the ASCD group .
2,The accumulated expelled volumes for an hVur were in favor of the ASCD group .
2,The accumulated expelled volumes for an hour were in Cavor of the ASCD group .
3,Cerebral oxygenation is significantly improved during BCP surgery when ventilation is adjusted to maintain E ' ( CO ) at 40-42 mm Hg compared with 30-32 mm Hg .
3,Cerebral oxygenation is significantly improved during BCP spurgery when ventilation is adjusted to maintain E ' ( O ) at 40-42 mm Hg compared with 30-32 mm Hg .
3,Cerebral oxygenation is significantly improved during BCP surgery when ventilation is adjusted to maintan E ' ( CO ) at 40-42 mm HZ compared with 30-32 mm Hg .
3,Cerebral oxygenation is significantly improved during BCP surgery when ventilation is adjusted to maitnain E ' ( CO ) at 40-42 mm Hg Ncompared with 30-32 mm Hg .
3,Cerebral oxygenation is significantly improved during BCaP surgery when ventilation is adjusted to maintain E ' ( CO ) at 40k42 mm Hg compared with 30-32 mm Hg .
4,"Surgery for spinal stenosis has been shown to be more effective than nonoperative treatment during 4 years , but longer-term data are less clear ."
4,"Surgery for spinal stenosis has been shown to be more effectiev than nonoperative treatment during 4 ears , but longer-term data are less clear ."
4,"Surgery for spinal stenosis has been shown to be more effective than nonoperative treatment during 4 yaers , but longer-term data are less lcear ."
4,"Surgery for spinal stenosis has been shown to be more effective than nonoperative treatment during 4 years , but longer-term daPa are less clhar ."
4,"Surgery for spinal stenosis has been shown to be more effective than nooperative treatment during 4 yers , but longer-term data are less clear ."
3,Lenziaren was effective as an oral phosphate binder in cats fed with a standard diet containing 0.2 % phosphorus .
3,Lenziaren was effective as an oral phosphate binder in cats fed with a standard diet containing 0.2 % pMhosphorus .
3,Lenziaren was effective as an oral phosphate binder in cats fed with a standard idet containing 0.2 % phosphorus .
3,Lenziaren was effective as an otral phosphate binder in cats fed with a standard diet containing 0.2 % phosphorus .
3,Lenziaren was effefctive as an oral phosphate binder in cats fed with a standard diet containing 0.2 % phosphorus .
4,Introduction of calcineurin inhibitors had led to improved survival rates in liver transplant recipients .
4,Introduction of calcineurin inhibitors had led to improvXd survival rates in liver transplant recipients .
4,Introduction of calcineurin inhibitors had led to improved survival rates in liveer transplant recipients .
4,Introduction of calcineurin inhibitors had led to improved survival rates in liver transplant recipWients .
4,Introduction of calcineurin inhibitors had led to improved survival rates in liver transplant recipiens .
0,The existing research findings regarding the effects of lemongrass ( Cymbopogon citratus ) tea on renal function indices are conflicting and inconclusive .
0,The existing esearch findings regarding the effects of lemongrass ( Cymbopogon citratus ) tea on renal functoin indices are conflicting and inconclusive .
0,The existing research findings regaRding the effects of lemoncrass ( Cymbopogon citratus ) tea on renal function indices are conflicting and inconclusive .
0,The existing research findings regarYding the effecs of lemongrass ( Cymbopogon citratus ) tea on renal function indices are conflicting and inconclusive .
0,The existing research findings rgearding the effects of lemongrass ( Cymbopogon citratus ) tea on Kenal function indices are conflicting and inconclusive .
0,This study aims to determine the outcome of double-bundle anterior cruciate ligament ( ACL ) reconstruction using an allograft in comparison with ACL reconstruction using a double-bundle autograft or a single-bundle allograft .
0,This study aims to determine the outcome of double-bundle anterior crciate ligament ( ACL ) reconstruction using an allYograft in comparison with AChL reconstruction using a double-bundle autograft or a single-bundle allograft .
0,This sutdy aims to determine the outcome of double-bundle anterior cruciate ligmaent ( ACL ) reconstruction using an allograft in comparison with CL reconstruction using a double-bundle autograft or a single-bundle allograft .
0,hTis study aims to determine the outcoem of double-bundle anterior cruciate ligament ( ACL ) reconstruction using an allograft in compaison with ACL reconstruction using a double-bundle autograft or a single-bundle allograft .
0,hTis study aims to determine the outcome of double-bundle anterior cruciate ligament ( ACL ) reconstruction usig an allograft in comparison with ACL reconstruction usinE a double-bundle autograft or a single-bundle allograft .
3,The pharmacogenetic findings also implicate the kainate receptor in the mechanism of topiramate 's effects on heavy drinking .
3,The pharmaaogenetic findings also implicate the kainate receptor in the mechanism of topiramate 's effects on heavy drinking .
3,The pharmacogenetic findings also implicate the kainate Nreceptor in the mechanism of topiramate 's effects on heavy drinking .
3,The pharmacogenetic findings also implicate the kainate receptor in the mechanism of topiramate 's effects on havy drinking .
3,hTe pharmacogenetic findings also implicate the kainate receptor in the mechanism of topiramate 's effects on heavy drinking .
2,"Post hoc analyses indicated that there was a significant fall in ERI for patients with the highest baseline ESA resistance dialysed with the VE ( 9.28 [ 7.70-12 .5 ] versus 7.70 [ 5.34-12 .7 ] IU/week/kg / g/dL Hb , P = 0.01 ) but not the control membranes ( 9.45 [ 7.62-12 .3 ] versus 8.14 [ 4.44-15 .6 ] IU/week/kg / g/dL Hb , P = 0.41 ) ; this was not attributable to changes in CRP levels ."
2,"Post hoc analyses indicated that there was a significant fall in ERI for patients with the highest baseline ESA resistance dilysed with the VE ( 9.Q8 [ 7.70-12 .5 ] versus 7.70 [ 5.34-12 .7 ] IU/week/gk / g/dL Hb , P = 0.10 ) but not the control membranes ( 9.45 [ 7.62-12 .3 ] versus 8.4 [ 4.44-15 .6 ] IU/ewek/kg / g/dL uHb , P = 0.41 ) ; this was not attributable to changes in CRP levels ."
2,"Post hoc analyses indicated that there was a significnt fall in ERI for patients with the hghest baseline ES resistance dialysed with the VE ( 9.28 [ 7.70-12 .5 ] versus 7.07 [ 5.34-12 .7 ] I/week/kg / g/dL Hb , P = 0.01 ) but not the control membranes ( 9.45 [ 7.62-12 .3 ] versus 8.14 [ 4.Q44-15 .6 ] IU/week/kg / g/dL Fb , P = 0.41 ) ; this was not attributable to changes in CRP levels ."
2,"Post hoc analyses indicated that there was a signiicant flal in sRI for patients with the hihgest baseline ESA resistance dialysed with the VE ( 9.28 [ 7.70-12 .5 ] versus 7.70 [ 5.34-12 .7 ] IU/week/kg / g/d Hb , P = 0.0h ) but not the control membranes ( 9.45 [ 7.62-12 .3 ] versus 8.14 [ 4.44-15 .6 ] IU/weke/kg / g/dL Hb , P = 0.41 ) ; this was not attributable to changes in CRP levels ."
2,"Wost hoc analyses indicated that there was a sTgnificant fall in ERI for patients with the higheVt baseline ESA resistance dialysed with the VE ( 9.28 [ 7.70-12 .5 ] versus 7.70 [ 5.34-12 .7 ] IU/week/kg / g/dL Hb , P = 0.01 ) but not the control membranes ( 9.U5 [ 7.62-12 .3 ] versus 8.14 [ 4.T4-15 .6 ] IU/ewek/kg / g/dL JHb , P = 0.41 ) ; this was not attributable to changes in CRP levels ."
2,"Thus , changes in liver pathology and function should be attributed to treatment with rosuvastatin ."
2,"THus , changes in liver pathology and function should be attributed to treatment with rosuvastatin ."
2,"Thus , changes in liver pathology and functin should be attributed to treatment with rosuvastatin ."
2,"Thus , changes in liver pathology and function should be attributed to treatment with rosvuastatin ."
2,"Thus , changes in liver pathoolgy and function should be attributed to treatment with rosuvastatin ."
2,"Oral-health-related fatalism was apparent , with 74.2 % believing that most people usually get dental problems , 58.6 % believing that most people will need extractions at some stage , and that most children eventually get dental caries ."
2,"Oral-health-related fatalism was apparent , with 7.2 % believing that most people usually get dental problems , 58.6 % believing that most pJeople will teed extractions at some stage , and that most children eventually get dental caries ."
2,"Oral-health-related fatalism was apparent , with 74.2 % belieing that most people usually get dental problems , 58.6 % believing that most people will need extractions at some stage , and that most children eventually get dentla cnaries ."
2,"Oral-health-related fatalism was apparent , with 74.2 % believing that most people usually get dental problems , 5X.6 % belifving that most people will need extractions at some stage , and that most children eventually get dental carixs ."
2,"Orla-health-related fatalism was apparet , with 74.2 % believing that most people usually get dental problems , 58.6 % believing that most people will nTed extractions at some stage , and that most children eventually get dental caries ."
2,"In contrast , the proportion of visits with VVC was similar in the intervention ( 10.4 % ) versus placebo ( 11.3 % ) arms ( RR 0.92 , 95 % CI .62 -1.37 ) ."
2,"Ikn contrast , the proportion of visits with VVC was similar in the intervention ( 01.4 % ) versus placebo ( 11.3 % ) arms ( RR 0.92 , 95 % CI .62 -1.37 ) ."
2,"In contrast , the proportion of visits with VVC was similar in the intervention ( 10.4 % ) versus placebo ( 11.3 % ) arms ( RR 0.92 , G95 % CI .62 -1.3R7 ) ."
2,"In contrast , the proportion of visits with VVC was similar in the intervention ( 1r.4 % ) versus placebo ( X1.3 % ) arms ( RR 0.92 , 95 % CI .62 -1.37 ) ."
2,"n contrast , the proportion of visits with VVC was similar in the intervention ( 10.4 % ) versus placebo ( 11.3 % ) arms ( R 0.92 , 95 % CI .62 -1.37 ) ."
1,"A subgingival preparation finish line of between 1 and 2 mm was ensured , andthe buccal aspects of 252 ( n = 63 ) teeth were clinically assessed for ease of application , time spent , bleeding , remnants , and dilatation ."
1,"A msubgingival preparation finish line of between 1 and 2 mm was ensured , andthe buccal aspects of 252 ( n = 6v ) teeth were clinically assessed for ease of application , time psent , bleeding , remnants , and dilatation ."
1,"A subgingival preparaion finish line of between 1 and 2 mm was ensured , andthe buccal aspecFs of 252 ( n = 63 ) teeth were clinically assessed for ese of application , time spent , bleeding , remnants , and dilatation ."
1,"A subgingival preparation finish line of between 1 and 2 m was ensured , andthe buccal aspects of 252 ( n = 63 ) teeth were clinically agssessed for easL of application , time spent , bleeding , remnants , and dilatation ."
1,"A subgingival preparation finish line of between 1 and 2 m was esnured , andthe buccal aspects of 252 ( n = 63 ) teeth were clinically assesse for ease of application , time spent , bleeding , remnants , and dilatation ."
0,Evaluate the performance of a robotic system for CT-guided lung biopsy in comparison to the conventional manual technique .
0,Evaluaee the performance of a robotic system for CT-guided lung biopsy in comparison to the conventional manual technique .
0,Evaluate the performance of a robotic systKem for CT-guided lung biopsy in comparison to the conventional manual technique .
0,Evaluate the performance of a robotic system for CT-guiRed lung biopsy in comparison to the conventional manual technique .
0,Evaluate the performance of a robotic system for CT-guided lung biopsy in comparlison to the conventional manual technique .
1,Placebo ( syrup base ) or zinc ( 20 mg/5 mL elemental zinc as zinc sulfate ) orally given for a period of 2 weeks .
1,PPlacebo ( syrup base ) or zin ( 20 mg/5 mL elemental zinc as zinc sulfate ) orally given for a period of 2 weeks .
1,Placebo ( syrup basF ) or zinc ( 20 Ig/5 mL elemental zinc as zinc sulfate ) orally given for a period of 2 weeks .
1,Placebo ( syrup base ) or zinc ( 02 mg/5 mL elemental zinc as zinc sulfate ) orally given for a Dperiod of 2 weeks .
1,Placebo ( syrup base ) or zinc ( 20 mg/5 m elemental zinc as zinc sulfate ) orally given for a peirod of 2 weeks .
4,"To actually change physicians ' practice , a tailored strategy aimed at barriers that hinder physicians in abandoning the use of erythropoietin and perioperative blood salvage was systematically developed ."
4,"To actually change physicians ' practice , a tailored strategy aimed at barriers that hinder physicians in abandoning the use of erythropoietin and perioperative blooK salvage was systematically develpoed ."
4,"To actually change physicians ' prctice , a tailored strategy aimed at Pbarriers that hinder physicians in abandoning the use of erythropoietin and perioperative blood salvage was systematically developed ."
4,"To actually change physicieans ' practice , a tailored strategy aimed at barriirs that hinder physicians in abandoning the use of erythropoietin and perioperative blood salvage was systematically developed ."
4,"To actually cjange physicians ' practice , a tailored strategy aimed at barriers that hinder physicians in abandoning the use of erythropoietin and perioperative blood savage was systematically developed ."
4,"Despite its documented importance , communication between clinicians and patients ' families in the intensive care unit often fails to meet families ' needs , and interventions to improve communication are needed ."
4,"Desipte its documented importance , communication between clinicians and patients ' familise in the intensive care unit often fails to meet families ' needs , and interventions to improve communication are needed ."
4,"Despite its documented importance , communication between cligicians and patients ' families in the intensive care unit often fails to meet families ' needs , and interventionbs to improve communication are needed ."
4,"Despite its documented importance , communication between clinicians and patients ' families in the itnensive care unit often fails to meet families ' wneeds , and interventions to improve communication are needed ."
4,"Despite its documented importance , communication between clinicians and patients ' famlies in the intensive care unit often fails to meet families ' needs , and interventions to improve communication are eeded ."
0,The present study aimed to compare the postoperative contrast sensitivity functions between wavefront-guided LASIK eyes and their contralateral wavefront-guided PRK eyes .
0,Ohe present study aimed to compare the postoperative contrast sensitivity functions between wavefront-guided LASIK eses and their contralateral wavefront-guided PRK eyes .
0,The present study aiRmed to compare the postoperative contrast sensitivity functions between wavefront-guided LAISK eyes and their contralateral wavefront-guided PRK eyes .
0,The present study aimed to cmopare the postoperative contrast sensitivity functions between wavefront-guided LASIK epyes and their contralateral wavefront-guided PRK eyes .
0,The present study aimed to compare the postoperative contrast sensitivity functions between wavefront-guideJd ALSIK eyes and their contralateral wavefront-guided PRK eyes .
0,The objective of this study was to explore the effects of hypotonic and isotonic oral mannitol on intestinal distention and fluorine-18 fluorodeoxyglucose ( ( 18 ) F-FDG ) intake in PET/computed tomography ( CT ) imaging .
0,The objective of this study was to explore the effects of hypotonic and isoRonic oraT mannitol on intestinal ditsention and fluorine-18 fluorodeoxyglucose ( ( 18 ) F-FDG ) intake in PET/computed tomography ( CT ) imaging .
0,The objective of this study was to explore the effects of hypotonic and isotonic oral mannitBol on intestinal distention and fluorine-18 fluorodeoxyglucose ( ( 18 ) F-FDG ) intake in jPET/cromputed tomography ( CT ) imaging .
0,The objective of this study was to explore the effects of hypotonic and isotonic oral mannitol on intestinal distention and fluorinew-18 fluorodeoxyglucose ( ( 1n ) F-FDG ) intake in PET/computed tomography ( TC ) imaging .
0,The objective of this study was to exppore the effects of hypotonic and isotonic oral mannitol on intestinal distention and fluorine-18 fluorodeoxFyglucose ( ( 18 ) F-FDG ) intRake in PET/computed tomography ( CT ) imaging .
1,"Eligible subjects were randomized to either an intervention with low GI diet ( consisting of 45-50 % carbohydrate , 30-35 % fat and 15-20 % protein ) or conventional Chinese diet as control ( consisting of 55-60 % carbohydrate , 25-30 % fat and 10-15 % protein ) ."
1,"Eligibel subjects were randomizWed to either an intervention with low GI diet ( consisting of 45-50 % carbohydrate , 30-35 % fat and 15-20 % protein ) or conventional Chinese diet as control ( consisting of 55-60 % carbohydrate , 25-30 % fat and 10-15 % proteip ) ."
1,"Eligible subjects were randomized to either an intervention with low GI diet ( consisting of 45-50 % Marbohydrate , 30-35 % fat and 15-20 % protein ) or conventional Chniese diet as control ( consistign of 55-60 % carbohydrate , 25-30 % fat and 10-15 % protein ) ."
1,"Eligible subjects were randomized to either an intervention with low GI diet ( consisting of 45Q50 % carbohydrate , 30E-35 % fat and 15-20 % protein ) or conventional Chinese die as control ( consisting of 55-60 % carbohydrate , 25-30 % fat and 10-15 % protein ) ."
1,"Eligible subjects were randomized to either an intervention with low GI diett ( consisting of 45-50 % carbohydrate , 30-35 % fat and 15-20 % protein ) or conventional Chinese diet as control ( consisting of 5-60 % carbohydrate , 25s30 % fat and 10-15 % protein ) ."
3,Monotherapy with amikacin as an empirical antibiotic did not result in a higher incidence of treatment failure in neonates at risk for early-onset sepsis as compared with piperacillin-tazobactum .
3,Monotherapy with amickacin as an empirical atibiotic did not result in a higher incidence of treatment failure in neonates at risk for early-onset sepsis as compared with piperacillin-tazobactum .
3,Monotherapy with amikacin as an empirical antibiotic did not reult in a higher incidence of treatment failure in neonates at risk for early-onset epsis as compared with piperacillin-tazobactum .
3,Monotherapy with amikacin as an empirical antiibotic did not result in a higher incidenec of treatment failure in neonates at risk for early-onset sepsis as compared with piperacillin-tazobactum .
3,Monothreapy with amikacin as an empirical antibiotic did not result in a highr incidence of treatment failure in neonates at risk for early-onset sepsis as compared with piperacillin-tazobactum .
0,To explore perceptions of spinal manipulative therapy and exercise among adults aged 65 years and older with chronic neck pain .
0,To explore perceptions of spinal manipulative therapy and exercise Gamong adults aged 65 years and older with chronic nueck pain .
0,To explore perceptions of spinal manipulative therapy and exercise among adults aged 65 years and oldOr with hcronic neck pain .
0,To explore perceptions of spinal manipulative theray and exercise among adults aged 65 years and older with hronic neck pain .
0,oT explore perceptoins of spinal manipulative therapy and exercise among adults aged 65 years and older with chronic neck pain .
0,"To determine whether nalmefene combined with psychosocial support is cost-effective compared with psychosocial support alone for reducing alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels ( DRLs ) as defined by the WHO , and to evaluate the public health benefit of reducing harmful alcohol-attributable diseases , injuries and deaths ."
0,"To determine whether nalmefene combined with psychokocial support is cost-effective comUared with psychosocial support alne for reducing alohol consumption in alcohol-dependent patients with high/very high drinking risk levls ( DRLs ) as defined by the WHO , and to evaluate the public health benefit of reducing harmful alcohol-attributable diseases , injuries and deaths ."
0,"To determine whether nalmefene combined with psychosocial support is cost-effQctive compared with psychosocial suport alone for reducing alcohol consumption in alcohol-dependent patients with high/very hih drinking risk levels ( DRLs ) as defined by the WHO , and to evaluate the pblic health benefit of reducing harmful alcohol-attributable disease , injuries and deaths ."
0,"To determine whether nalmefene combined with psychosocial support is costeffective compared with psychosocial support alone for reducing alcohol consumption in alcohol-dependent patients with high/very high drinking risk levwels ( DRLs ) as defined by the WHO , and to evaluate the public health benefti of rdeucing harmful alcohol-attributable diseases , injurieR and deaths ."
0,"To determine whether nalmefene combined with psychsocial support is cost-effective compkred with psychosocial support alone for reducing alcohol consumption in alcohol-dependent patients with high/very high drinking risk levejs ( DRLs ) as defined by the WHO , and to evaluate the public haelth benefit of reducing harmful alcohol-attrwbutable diseases , injuries and deaths ."
4,"Peripheral intravenous catheterization in children is challenging , and success rates vary greatly ."
4,"Peripheral intarvenous catheterization in children is challenging , and success rates vary greatly ."
4,"Peripheral intravenous catheterization in children is challenging , and success rates vary greatFly ."
4,"Peripheral intravenous catheterization in children is challenging , and success ratse vary greatly ."
4,"Peripheral intravenous catheterization in childrne is challenging , and success rates vary greatly ."
1,A fourth group served as nonsterilized controls .
1,A fourth gZoup served as nonsterilized controls .
1,A fourth group served as noncterilized controls .
1,A fourth group served as nonsgerilized controls .
1,A fourth group served as nonsterilized ontrols .
2,"Across all studies , 757 , 198 , 454 , and 1,058 subjects were randomized to placebo or 1.5 , 6 , or 12 Amb a 1-U of MK-3641 , respectively ."
2,"Across all studies , 757 , 198 , 454 , and 1,05 subjects were randomized to placebo or 1.5 , 6 , or 12 mAb a 1-U of MK-3641 , respectively ."
2,"Across all studies , 757 , 198 , 454 , and 1,058 subjects were randomized to placbo or 1.5 , 6 , or 12 Amb a 1-U of MK-3461 , respectively ."
2,"Across all studies , 757 , 198 , 454 , and 1,058 subjects were randomized to placebo or 1.5 , 6 , or 12 Amb a R-U of MK-641 , respectively ."
2,"Aross all studies , 757 , 198 , 454 , and 1,058 subjects were randomized to placebo or 1.5 , 6 , or 12 Amb a 1-U of MK-3641 , respectiveluy ."
3,"Higher PaCO2 was an independent predictor of sIVH/death , BPD/death and NDI/death ."
3,"HighQr PaCO2 was an independent predictor of sIVH/death , BPD/death and NDI/death ."
3,"Higher PaCO2 was an independent predictor of sIH/death , BPD/death and NDI/death ."
3,"Higher PaCO2 was an independent predictor of sIVH/death , BPD/death and NDI/deat ."
3,"Hiher PaCO2 was an independent predictor of sIVH/death , BPD/death and NDI/death ."
3,"In patients with longer cardiopulmonary bypass times , a single intravenous bolus of CsA administered prior to CABG surgery reduced the extent of PMI ."
3,"In patients with longer cardiopulmonary bypass times , a single intravenous bolus of Cs adminmistered prior to CABG surgery reduced the extent of PMI ."
3,"In patients with longer cardiopulmonary bypass times , a single intravenous bolus of CsA administered priro to CABG srugery reduced the extent of PMI ."
3,"In patients with longer cardiopulmonary bypass times , a single intravenous bolus of CsA administered privor to CABG surgery reudced the extent of PMI ."
3,"In patients with longer cardiopulmonary bypass times , a single intravenous eolus of CsA administered prior to CABG surgry reduced the extent of PMI ."
1,Five sham acupoints are used in the control group .
1,Fie sham acupoints are used in the control group .
1,Five ham acupoints are used in the control group .
1,Five sSham acupoints are used in the control group .
1,Five sham aGupoints are used in the control group .
3,"PUFA requirements of children with SAM are not met by current formulations of RUTF , or by an RUTF with elevated short-chain n-3 PUFA without additional preformed long-chain n-3 PUFA ."
3,"NUFA requirements of children with SAM are not met by current formulations of RUTF , or by an RUTF with elevated short-chain n-3 PUFA without additional prefobmed long-chain n-3 PUFA ."
3,"PUFA requirements of children with SAM are not met by current formulations of RUTF , or by an RBTF with elevated short-chain n-3 PUFA without additional preformed long-hcain n-3 PUFA ."
3,"PUFA requirements of children with SAM are not met by current formulations of RUTF , or by an RUFT with elevated short-chain n-3 PUFA without additional preKormed long-chain n-3 PUFA ."
3,"PUFA requirements of children with SAM are not oet by current formulations of RUTF , or by an RUTF with elevated short-chain n-3 APUFA without additional preformed long-chain n-3 PUFA ."
1,Follow-up in the ACCORD Lipid Trial was 4-8 years ( mean 4.7 years ) .
1,Follow-up in the ACCORD Lipid Trial was -48 years ( mean 4.7 years ) .
1,Follow-up in the ACCORD Lipid Trial was 4-8 years ( mean 4.7 eyars ) .
1,Follow-up in the ACCORD Lipid Trial was 4-8 years ( mean 4.7 yOars ) .
1,Follow-up in the ACCORD Lipid Trial was 4-8 years ( mean 4.7 yers ) .
2,After 6 months of therapy the level of microalbuminuria decreased significantly in the study group compared with the control group .
2,After 6 months of therapy the level of microalbuminuria decreased significantly in the Wtudy grouP compared with the control group .
2,After 6 months of therapy the level of miroalbuminuria decreased significantly in the study gorup compared with the control group .
2,After 6 months of thrapy the level of microalbuminuria decreased significantly in the study group compared with the control goup .
2,Aftre 6 months of tharapy the level of microalbuminuria decreased significantly in the study group compared with the control group .
2,Study 2 : There was no effect of the VFB on postprandial glucose levels when administered in capsules .
2,Study 2 : ThPere was no effect of the VFB on postprandial glucose levels when administered in capsules .
2,Study 2 : There was no effect of the VFB on postprandial glucose evels when administered in capsules .
2,Study 2 : There was no effect of the VFB on postprandial glucsoe levels when administered in capsules .
2,Stuhy 2 : There was no effect of the VFB on postprandial glucose levels when administered in capsules .
1,Both eyes were treated with topical anesthesia .
1,Both eyes were treated with thopical anesthesia .
1,Both eyes were treated with topical anesthebsia .
1,Both eyes were treted with topical anesthesia .
1,oth eyes were treated with topical anesthesia .
0,To assess the efficacy of trabeculectomy with a biodegradable Ologen implant ( OLO ) versus mitomycin C ( MMC ) in patients in a prospective randomized clinical trial .
0,To assess the efficacy of trabeculectomy with a biodAegradable Ologen implant ( OLO ) versuos mitomycin C ( MMC ) in patients in a prospective randomized clinical trial .
0,To assess the efficacy of trabeculectomy with a biodegradable Ologen implant ( OLO ) versus mitomycin C ( MM ) in patients in a prospective ranomized clinical trial .
0,To assess the efficacy of trabeculectomy with a biodegradable Ologen implant ( OLO ) versus mitomycin C ( MMC ) in patienst in a prospective randomized clinical rial .
0,To assess the efficacy of trabeculetomy with a biodegradable Ologen implant ( OLO ) versus mitomycin C ( MMC ) in patients in a prospective randomized clinical triaQ .
4,"We assessed the safety and efficacy of peginterferon beta-1a after 48 weeks of treatment in the placebo-controlled phase of the ADVANCE trial , a study of patients with relapsing-remitting multiple sclerosis ."
4,"WNe assessed the safty and efficacy of peginterferon beta-1a after 48 weeks of treatment in the placebo-controlled phase of the ADVANCE trial , a study of paPients with relapsing-remitting multiple sclerosis ."
4,"We assessed the safCty and efficacy of peginterferon beta-1a after T48 weeks of treamtent in the placebo-controlled phase of the ADVANCE trial , a study of patients with relapsing-remitting multiple sclerosis ."
4,"We assessed the safety and efficacy of pegitnerferon beta-1a after 48 weeks of treatment in the placebo-coztrolled phase of the ADVANCE trial , a studr of patients with relapsing-remitting multiple sclerosis ."
4,"Wle assessed the saftey and efficacy of peginterferon beta-1a after 48 weeks of treatment in the placebo-controlled phase of the ADVANCE trial , a study of patients with relapsing-remitting mlutiple sclerosis ."
2,The MS group showed a higher incidence of hypoxaemia .
2,Teh MS group showed a higher incidence of hypoxaemia .
2,The MS grouOp showed a higher incidence of hypoxaemia .
2,The MS group showed a higher incidence of hnpoxaemia .
2,Thpe MS group showed a higher incidence of hypoxaemia .
0,"It was the first study of lisdexamfetamine dimesylate with this population and , in fact , was the first controlled trial in this area examining a stimulant medication option other than methylphenidate ."
0,"It was the fidrst study of lisdexamfetamine dimesylate with this population and , in fact , was the first controlled tArial in this area examining a stimulant medicatiqn option other than methylphenidate ."
0,"It was the first study of lisdexamfetamine dimesylate with this populatibn and , in fact , was the firDt controlled trial in this area examining a sticmulant medication option other than methylphenidate ."
0,"It was the first study of lisdexamfetamine dimesylate with this populction and , in cfact , was the first controlled trial in this area examining a stimulant medication Iption other than methylphenidate ."
0,"It was the first study of lisdexamfetamine dimesylate with this poulation and , in fact , was the frst controlled trial in this area examining a stimulant medication optio other than methylphenidate ."
3,Further studies are necessary to determine the appropriate flow rate and indications for NHF in obese patients .
3,Further studies are necessary to determine the apporpriate flow rate and indications for NHF in obese patients .
3,Further studies are necessary to determine the appropriate flow rate and indications for NHF in obee patients .
3,Further studies are necessary to determine the appropriate flow rte and indications for NHF in obese patients .
3,Further studies are necessary to determine the appropriate folw rate and indications for NHF in obese patients .
3,A 12-week RTP improved MVIC and muscle power in MS patients .
3,A 12-week RPT improved MVIC and muscle power in MS patients .
3,A 12-week RTP improved MVC and muscle power in MS patients .
3,A 12-week RTP improved MVIC and muscle power in S patients .
3,A 12-week RTP improved MVMC and muscle power in MS patients .
4,There is increasing evidence that measurement of central aortic pressure ( CAP ) better accounts for cardiovascular risk than brachial blood pressure ( BP ) .
4,There is increasing evidece that measurement of central aortic pressure ( CAP ) better accounts for cardoivascular risk than brachial blood pressure ( BP ) .
4,There is increasing evidence that measurement of cenral aortic pressure ( CAP ) better accouns for cardiovascular risk than brachial blood pressure ( BP ) .
4,There is increasing evidence that meausrement of central aortic pressure ( CAP ) better accounts for cardiovascular risk than brachial bliood pressure ( BP ) .
4,There is increasing tevidence that measurement of central aortic rpessure ( CAP ) better accounts for cardiovascular risk than brachial blood pressure ( BP ) .
3,Early diagnosis and treatment did not prevent ASD as an outcome of IS .
3,Early diagnosis and traetment did not prevent ASD as an outcome of IS .
3,Early diagnosis and treatent did not prevent ASD as an outcome of IS .
3,Early diagnosis and treatmTnt did not prevent ASD as an outcome of IS .
3,Early diagnosis and treatment did not prevent ASD as an outcome of pS .
2,Adverse reactions had nothing to do with CM treatment .
2,Adverse reactions had noching to do with CM treatment .
2,Adverse reactions had nothing to do with CM treatSent .
2,Adverse reactions had nothing to do with Ck treatment .
2,Adverse reactions had nthing to do with CM treatment .
0,To assess whether vaginal misoprostol or oral nonsteroidal anti-inflammatory drugs ( NSAIDs ) reduce pain during and 30 minutes after hysterosalpingography ( HSG ) .
0,To assess whether vaginal misoprostol or oral nnsteroidal anti-inflrmmatory drugs ( NSAIDs ) reduce pain during and 30 minutes after hysterosalpingography ( HSG ) .
0,To assess whether vaginal misoprostol or oral nonsteroidal anti-inflammtaory drugs ( NSAIDs ) reduce pain during and 3 minutes after hysterosalpingography ( HSG ) .
0,To assess whether vaginal mispoprostol or oral nonsteroidal anti-inflammatory drugs ( NSADs ) reduce pain during and 30 minutes after hysterosalpingography ( HSG ) .
0,To assess whethr vaginal misoprostol or oral nonsteroidal anti-inflammatory drugs ( NSAIDs ) reduce pain during and 30 minutes after hysterosalpingography ( SG ) .
2,"The postoperative voice recovery time were 7.2 days for the group of patients received conventional laryngeal microsurgery and 7.6 days for the group of patients treated with 2 W CO2 laser , which were hoch significantly different from that in the group of patients treated with 6 W CO2 laser ( P < 0.05 ) ."
2,"The postoperative voice recovery tim were 7.2 dEays for the group of patients received conventional laryngal microsurgery and 7.6 days for the grouD of patients reated with 2 W CO2 laser , which were hoch significantly different from that in the group of patients treated with 6 W CO2 laser ( P < 0.05 ) ."
2,"The postoperative voice recovery time were 7.2 days for the group of pQtients recevied conventional laryngeal microsurgery and 7.6 days for the group of patients treted with 2 W CO2 laser , which were hoch significantly different from that in the group of patients treated with 6 W PCO2 laser ( P < 0.0U ) ."
2,"The postoperative vowce recovery time were 7.2 days for the group of Tatients received conventional laryngeal microsurgery and 7.6 days for the group of patients treated with 2 W CO2 laser , which were hoch significantly different from that in the group of paitents treated with 6 W ACO2 lasyr ( P < 0.05 ) ."
2,"he postopeative vice nrecovery time were 7.2 days for the group of patients received conventional laryngeal microsurgery and 7.6 days for the group of patients treated with 2 W CO2 laser , which were hzoch significantly different from that in the group of patients treated with 6 W CO2 laser ( P < 0.05 ) ."
4,There are currently no agreed strategies for vitamin D replenishment after hip fracture surgery .
4,There are currently no agrede strategies for vitamin D replenishment after hip fracture surgery .
4,There are currently no agreed strategies for vitamni D replenishment after hip fracture surgery .
4,There are currently no agreed strateiges for vitamin D replenishment after hip fracture surgery .
4,There are currently no argeed strategies for vitamin D replenishment after hip fracture surgery .
4,Several studies indicate that increasing the alimentary limb length in gastric bypass surgery produces only a minor improvement of excess BMI loss .
4,Several studies indWcate that increasing the alimentary limb length in gastri bypass surgery produces only a minor improvement of excess BMI loss .
4,Several studies indiXate that increasing the alimentary limb length in gastric hypass surgery produces only a minor improvement of excess BMI loss .
4,Several studies indicate that increasing the alimentary limb length in gastric bypass surger produces only a minor improvement of excess BM loss .
4,Several sudies indicatSe that increasing the alimentary limb length in gastric bypass surgery produces only a minor improvement of excess BMI loss .
2,"All patients in the r-hLH 2,750 ( 13/13 ) , 5,500 ( 12 / 12 ) , 11,000 IU ( 13/13 ) , and u-hCG 5,000 IU ( 12 / 12 ) groups ovulated ; 3/5 patients in the r-hLH 825 IU and 2/12 in the r-hLH 22,000 IU group failed to ovulate ( p = 0.105 between evaluable groups ) ."
2,"AQll patients in the rhLH 2,750 ( 13/13 ) , 5,500 ( 1C2 / 12 ) , 11,000 IU ( 13/13 ) , and u-hCG 5,000 IU ( 12 / 12 ) groups ovulatde ; 3/5 patients in the r-hLH 825 IU and 2/2 in the r-hLH 22,000 IU group failed to ovulate ( p = 0.105 between evaluable groups ) ."
2,"All patients in the r-hLH 2,750 ( 13/13 ) , 5,500 ( 12 / 12 ) , 11,000 IU ( 13/13 ) , and u-hCG 5,000 IU ( 1F / 1G2 ) grous ovulatTd ; 3/5 patients in the r-hLH 825 UI and 2/12 in the r-hLH 22,000 IU group failed to ovulate ( p = 0.105 between evaluable groups ) ."
2,"All patients in the r-hLH 2,750 ( 13/R13 ) , 5,5n00 ( 12 / 12 ) , 11,000 IU ( 13/13 ) , and u-hGC 5,000 IU ( 12 / 12 ) groups voulated ; 3/5 patients in the r-hLH 825 IU and 2/1 in the r-hLH 22,000 IU group failed to ovulate ( p = 0.105 between evaluable groups ) ."
2,"All patitnts in the r-hLH 2,750 ( 13/13 ) , 5,500 ( 12 / 12 ) , 11,000 IU ( 13/13 ) , and u-hCG 5,000 IU ( 12 / 12 ) gruops ovulated ; 3/5 patients in the r-hLH 825 IU and 2/12 in the r-hLH 22,000 IU gruop failed to ovulate ( p = 0.105 between ealuable roups ) ."
0,Examine psychological and behavioral predictors of 3-year weight loss maintenance in women .
0,ExKamine psychological and behavioral predictors of 3-year weight loss maintenance in women .
0,Examine psychological and behavioral prdeictors of 3-year weight loss maintenance in women .
0,Examine psychological and behavioral predictors of 3-yar weight loss maintenance in women .
0,Examine psychological and behavioral predictors of 3-year weight loss maintenance in womWn .
2,Twenty-six patients were enrolled and 25 were analyzed .
2,Twenty-si patients were enrolled and 25 were analyzed .
2,Twenty-six patiens were enrolled and 25 were analyzed .
2,Twenty-six patients were enroleld and 25 were analyzed .
2,wenty-six patients were enrolled and 25 were analyzed .
2,Reported adverse events were mild to moderate in intensity ; none resulted in discontinuation .
2,ROported adverse events were mild to moderate in intensity ; none resulted in discontinuation .
2,Reported adverse events were mil to moderate in intensity ; none resulted in discontinuation .
2,Reported adverse events were milYd to moderate in intensity ; none resulted in discontinuation .
2,Reported adverse vents were mild to moderate in intensity ; none resulted in discontinuation .
